<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Inflammopharmacology</journal-id><journal-id journal-id-type="iso-abbrev">Inflammopharmacology</journal-id><journal-id journal-id-type="pmc-domain-id">3814</journal-id><journal-id journal-id-type="pmc-domain">phenaturepg</journal-id><journal-title-group><journal-title>Inflammopharmacology</journal-title></journal-title-group><issn pub-type="ppub">0925-4692</issn><issn pub-type="epub">1568-5608</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer Nature - PMC COVID-19 Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC9321285</article-id><article-id pub-id-type="pmcid-ver">PMC9321285.1</article-id><article-id pub-id-type="pmcaid">9321285</article-id><article-id pub-id-type="pmcaiid">9321285</article-id><article-id pub-id-type="pmid">35882701</article-id><article-id pub-id-type="doi">10.1007/s10787-022-01037-4</article-id><article-id pub-id-type="publisher-id">1037</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Effects of <italic toggle="yes">Boswellia</italic> species on viral infections with particular attention to SARS-CoV-2</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Jamshidi</surname><given-names initials="Z">Zahra</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hashemi</surname><given-names initials="M">Maryam</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yazdian-Robati</surname><given-names initials="R">Rezvan</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Etemad</surname><given-names initials="L">Leila</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Salmasi</surname><given-names initials="Z">Zahra</given-names></name><address><email>salmasiz@mums.ac.ir</email></address><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0890-769X</contrib-id><name name-style="western"><surname>Kesharwani</surname><given-names initials="P">Prashant</given-names></name><address><email>prashantdops@gmail.com</email></address><xref ref-type="aff" rid="Aff8">8</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.411583.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2198 6209</institution-id><institution>Student Research Committee, </institution><institution>Mashhad University of Medical Sciences, </institution></institution-wrap>Mashhad, Iran </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.411583.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2198 6209</institution-id><institution>Department of Medicinal Chemistry, </institution><institution>Mashhad University of Medical Sciences, </institution></institution-wrap>Mashhad, Iran </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.411583.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2198 6209</institution-id><institution>Nanotechnology Research Center, Pharmaceutical Technology Institute, </institution><institution>Mashhad University of Medical Sciences, </institution></institution-wrap>Mashhad, Iran </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.411583.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2198 6209</institution-id><institution>Department of Pharmaceutical Biotechnology, School of Pharmacy, </institution><institution>Mashhad University of Medical Sciences, </institution></institution-wrap>Mashhad, Iran </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.411623.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2227 0923</institution-id><institution>Molecular and Cell Biology Research Center, Faculty of Medicine, </institution><institution>Mazandaran University of Medical Sciences, </institution></institution-wrap>Sari, Iran </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.411583.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2198 6209</institution-id><institution>Pharmaceutical Research Center, Pharmaceutical Technology Institute, </institution><institution>Mashhad University of Medical Sciences, </institution></institution-wrap>Mashhad, Iran </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.411583.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 2198 6209</institution-id><institution>Department of Pharmaceutical Nanotechnology, School of Pharmacy, </institution><institution>Mashhad University of Medical Sciences, </institution></institution-wrap>P.O. Box, 91775-1365 Mashhad, Iran </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.411816.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 0498 8167</institution-id><institution>Department of Pharmaceutics, </institution><institution>School of Pharmaceutical Education and Research, Jamia Hamdard, </institution></institution-wrap>New Delhi, 110062 India </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>7</month><year>2022</year></pub-date><pub-date pub-type="ppub"><year>2022</year></pub-date><volume>30</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">413088</issue-id><fpage>1541</fpage><lpage>1553</lpage><history><date date-type="received"><day>27</day><month>6</month><year>2022</year></date><date date-type="accepted"><day>7</day><month>7</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>07</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>27</day><month>07</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-29 13:25:36.547"><day>29</day><month>03</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10787_2022_Article_1037.pdf"/><abstract id="Abs1"><p id="Par1">The emergence of pathogenic viruses is a worldwide frequent cause of diseases and, therefore, the design of treatments for viral infections stands as a significant research topic. Despite many efforts, the production of vaccines is faced with many obstacles and the high rate of viral resistance caused a severe reduction in the efficacy of antiviral drugs. However, the attempt of developing novel natural drugs, as well as the exertion of medicinal plants, may be an applicable solution for the treatment of viral diseases. <italic toggle="yes">Boswellia</italic> species exhibited a wide range of pharmacological activities in various conditions such as bronchial asthma, rheumatism, and Crohn&#8217;s illness. Additionally, pharmacological studies reported the observance of practical antiviral activities from different parts of this substance, especially the oleo-gum-resin. Therefore, this work provided an overview on the antiviral properties of <italic toggle="yes">Boswellia</italic> species and their potential therapeutic effects in the field of COVID-19 pandemic.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd><italic toggle="yes">Boswellia</italic> species</kwd><kwd>Antiviral effect</kwd><kwd>SARS-CoV-2</kwd><kwd>Natural therapies</kwd><kwd>Herbal medicine</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Switzerland AG 2022</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">Viral diseases are one of the most common worldwide health obstacles (Meganck and Baric <xref ref-type="bibr" rid="CR56">2021</xref>). Viruses are classified into two species including DNA virus and RNA virus,&#8207; &#8207;which are generally consisted of double-strand or single-strand. Single-stranded RNA viruses contain positive-sense-single-stranded RNA or negative-sense-single-stranded RNA (Durmu&#351; and &#220;lgen <xref ref-type="bibr" rid="CR26">2017</xref>; Hughes and Hughes <xref ref-type="bibr" rid="CR37">2007</xref>). Accordingly, human diseases caused by RNA viruses involve SARS, common cold, influenza, and hepatitis C or E, as well as Coronavirus disease (COVID-19) that is induced by the SARS-CoV-2 virus. The treatment of viral infections are typically a difficult challenge mainly due to the virus mutations, drug resistance, side effects, and high cost of antiviral medicines (Cosar et al. <xref ref-type="bibr" rid="CR20">2021</xref>; Caligiuri et al. <xref ref-type="bibr" rid="CR16">2016</xref>; Behravan et al. <xref ref-type="bibr" rid="CR9">2011</xref>). The attention of many scientists was focused on bioactive compounds, secondary metabolites, and the phytochemicals of medicinal plants for the design and development of legal drugs against viral diseases, which would lack or at least contain the most negligible rate of side effects (Jansi et al. <xref ref-type="bibr" rid="CR40">2021</xref>; Jassim and Naji <xref ref-type="bibr" rid="CR41">2003</xref>). As a genus of the Burseraceae family, <italic toggle="yes">Boswellia</italic> species were traditionally exerted for the treatment of numerous diseases such as chronic inflammatory illnesses, arthritis, blood disorders, cardiovascular diseases, diarrhea, ringworm, vaginal discharges, jaundice, fevers, mouth sores, dire throat, bronchitis, asthma, coughing, hair loss, hemorrhoids, syphilitic diseases, diaphoretic, astringent, and diuretic (Rashan et al. <xref ref-type="bibr" rid="CR71">2019</xref>; Upaganlawar and Ghule <xref ref-type="bibr" rid="CR86">2009</xref>). Different parts of <italic toggle="yes">Boswellia</italic> species such as roots, barks, leaves and oleo-gum-resin, can be used as safe therapeutic agents with potent antioxidant, antimicrobial, anti-inflammatory, anticancer, anticoagulant, antidepression, and antifungal activities (Prakash et al. <xref ref-type="bibr" rid="CR69">2014</xref>; Marefati et al. <xref ref-type="bibr" rid="CR55">2022</xref>; Bhushan et al. <xref ref-type="bibr" rid="CR11">2013</xref>; Pan et al. <xref ref-type="bibr" rid="CR65">2015</xref>; Adake et al. <xref ref-type="bibr" rid="CR1">2013</xref>).</p><p id="Par3">Nowadays, a wide range of brand formulations composed of <italic toggle="yes">Boswellia</italic> species, including 5-Loxin<sup>&#174;</sup>, Aflapin<sup>&#174;</sup>, and Sallaki<sup>&#174;</sup>, are exerted for different purposes such as hepatoprotective, antiarthritic, antihyperlipidemic, antiinflammatory, antiatherosclerotic, and analgesic activities (Sengupta et al. <xref ref-type="bibr" rid="CR76">2010</xref>; Knaus and Wagner <xref ref-type="bibr" rid="CR48">1996</xref>; Sharma et al. <xref ref-type="bibr" rid="CR87">2016</xref>). This review presented a summary on the antiviral effects of <italic toggle="yes">Boswellia</italic> species with a focus on its potent beneficial abilities against COVID-19 for the development of an alternative therapy in near future.</p></sec><sec id="Sec2"><title>Search strategy</title><p id="Par4">The relevant articles were retrieved through the application of scientific databases such as &#8220;Google Scholar,&#8221; &#8220;Scopus,&#8221; &#8220;PubMed,&#8221; &#8220;Science Direct,&#8221; and &#8220;Wiley Online Library&#8221; using the keywords &#8220;<italic toggle="yes">Boswellia</italic>&#8221; or &#8220;<italic toggle="yes">frankincense</italic>&#8221; and &#8220;virus&#8221; or &#8220;viral.&#8221; We also gathered information from related local and foreign books.</p></sec><sec id="Sec3"><title>Botany and phytochemistry</title><p id="Par5">Bursereae, Canarieae, and Protieae are the three subtribes of Burseraceae family, which include 19 genera, as well as approximately 700 species that are all shrubby and small to medium trees (2&#8211;8&#160;m in height). Next to the exfoliated outer bark, the smaller leaves are glabrous&#8207; &#8207;with 7&#8211;9 tiny toothy leaflets. The flowers are composed of five lobes with disk-shaped internal stamens. The genus Boswellia is approximately consisted of 21 species that are native to Africa, southern Arabia, and India (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>&#8207;(&#8207;. <italic toggle="yes">Boswellia</italic> species is bisexual with self-pollinate properties and grows in regions with hot and dry climate&#8207; (Siddiqui <xref ref-type="bibr" rid="CR79">2011</xref>; Sultana et al. <xref ref-type="bibr" rid="CR84">2106</xref>). The diversity of various active phytocompounds that exist in this genus are caused by variable weather and climate (Rashan et al. <xref ref-type="bibr" rid="CR71">2019</xref>; Kadam et al. <xref ref-type="bibr" rid="CR43">2021</xref>; Pilkhwal and Dhaneshwar <xref ref-type="bibr" rid="CR68">2019</xref>). Oleo-gum-resin is exuded from scratching the surface of <italic toggle="yes">Boswellia</italic>&#8207; &#8207;tree,&#8207; &#8207;which is an aromatic resin with a clear, sweet-smelling, and golden yellow appearance. The prominent producers of Oleo-gum-resin are comprised of four species including <italic toggle="yes">B. carteri</italic>, <italic toggle="yes">B. frereana</italic>, <italic toggle="yes">B. sacra</italic>, and <italic toggle="yes">B. serrata</italic> (Greve et al. <xref ref-type="bibr" rid="CR32">2017</xref>; DeCarlo et al. <xref ref-type="bibr" rid="CR24">2018</xref>; Johnson et al. <xref ref-type="bibr" rid="CR42">2021</xref>). This material is consisted of essential oil, gum, and resin. The essential oil of <italic toggle="yes">Boswellia</italic> species contains various components such as monoterpene, diterpene, sesquiterpene, ether derivatives of alcohol, and ester derivatives that are capable of displaying different activities including antioxidant, acetyl-cholinesterase-inhibition, antimicrobial, anticancer, and antibiofilm effects (Satpathy <xref ref-type="bibr" rid="CR74">2020</xref>; Sharma et al. <xref ref-type="bibr" rid="CR77">2007</xref>; Gupta et al. <xref ref-type="bibr" rid="CR33">2011</xref>; Aldahlawi et al. <xref ref-type="bibr" rid="CR3">2020</xref>). Moreover, the gum is composed of different sugars including arabinose, xylose, and galactose (Sharma et al. <xref ref-type="bibr" rid="CR77">2007</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>The images of some species from <italic toggle="yes">Boswellia</italic>. <bold>A</bold>
<italic toggle="yes">B. carteri</italic>, <bold>B</bold>
<italic toggle="yes">B. serrata</italic></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="10787_2022_1037_Fig1_HTML.jpg"/></fig></p><p id="Par6">In addition to oleo-gum-resin, the other parts of this plant such as the leaves, roots, and bark can be exerted for the treatment of various diseases and disorders. A study reported the achievement of varying chemical compositions from different extracts of <italic toggle="yes">B. dalzielii</italic>&#8207; &#8207;leaves, which included phenolics, flavonoids, tannins, anthocyanins, and sugar. The highest and lowest yields&#8207; &#8207;were recorded in the cases of methanol (16.08%) and ethyl acetate (0.03%) extracts, respectively, while the product was 1.12% of the mass of dry leaves in the case of essential oil. Apparently, dissimilar pharmacological impacts were observed from different types of extracts. For instance, the inhibition percentage of cyclohexane extract in IGROV-1 cell lines was 92.60%, whereas the dichloromethane extract caused 65.10% of inhibition in OVCAR-3 cell lines. However, there were no signs of any toxic effects from methanolic extract (Kohoude et al. <xref ref-type="bibr" rid="CR49">2017</xref>). <italic toggle="yes">Boswellia</italic> resin is a mixture of more than 200 diverse ingredients such as b-boswellic acid, acetyl-b-boswellic acid, 11-keto-b-boswellic acid, acetyl-ll-keto-b-boswellic acid, 3a-hydroxy-urs-9, 12-diene-24-oic acid, 3a-Hydroxy-lup-20(29)-en-24-oic acid, 3 hydroxyl urs-9, and 11-keto-&#945;-boswellic acid. In addition, this resin is capable of displaying different activities similar to antiinflammatory, antiarthritic, antiulcer, and analgesic effects.</p></sec><sec id="Sec4"><title>Safety and toxicity of <italic toggle="yes">Boswellia</italic> species</title><p id="Par7">Certain investigations were performed on the Safety and toxic properties of <italic toggle="yes">Boswellia</italic> species in different animal models. Singh et al. reported the oral administration of <italic toggle="yes">B&#8207;.&#8207; serrata</italic> in rat models for 90&#160;days at three different doses, i.e. 100, 500, and 1000&#160;mg/kg body weight (B. wt.) /day. Their results confirmed the safety of <italic toggle="yes">B&#8207;.&#8207; serrata</italic> in dosages up to 500&#160;mg/kg B.wt. without the inducement of any side effects (Singh et al. <xref ref-type="bibr" rid="CR81">2012</xref>). According to recent studies, different cytogenetic test results approved the ability of boswellic acids in facilitating a high rate of safety in Wistar rats, while lacking any signs of toxicity up to 1000&#160;mg/kg when compared to positive controls (Sharma et al. <xref ref-type="bibr" rid="CR78">2009</xref>).</p></sec><sec id="Sec5"><title>Antiviral activities</title><p id="Par8">Next to being exerted for vaccine formulations, <italic toggle="yes">Boswellia</italic> species can produce a variety of bioactive constituents with the potential of inhibiting different types of DNA or RNA viruses similar to Influenza, Hepatitis C, Chikungunya, Vesicular stomatitis, Epstein&#8211;Barr, Herpes Simplex, Newcastle disease, and Avian Infectious bronchitis viruses (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>(.<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Antiviral activities of <italic toggle="yes">Boswellia</italic> species</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="10787_2022_1037_Fig2_HTML.jpg"/></fig></p><sec id="Sec6"><title>Hepatitis C virus (HCV)</title><p id="Par9">Hepatitis C virus (HCV) is a universal health concern due to standing as the main cause of liver inflammation and injury. The envelopment of this virus implicates positive polarity and single-stranded RNA virus that belongs to the Flaviviridae family (Vega and Barbancho <xref ref-type="bibr" rid="CR23">2020</xref>). There are currently no competent vaccines or efficient antiviral medicines available against hepatitis C. However, the exerted combination therapies include pegylated interferon alpha (PegIFN-&#945;) injections and antiviral nucleoside analogue ribavirin (RBV) that cause many side effects such as hyperglycemia, pancreatitis, hypertension, and peptic ulcer, as well as fever, flu, anemia, and depression (Schaefer et al. <xref ref-type="bibr" rid="CR75">2007</xref>). Hussein et al. performed an assessment on the inhibitory impacts of 76 plants, which are commonly used in Sudanese for the treatment of hepatitis C virus (HCV) protease (PR). Apparently, eight samples displayed notable antiviral inhibitory activity including <italic toggle="yes">Acacia nilotica</italic>, <italic toggle="yes">Piper cubeba</italic>, <italic toggle="yes">Embelia schimperi</italic>, <italic toggle="yes">Quercus infectoria</italic>, <italic toggle="yes">Trachyspermum ammi</italic>, <italic toggle="yes">Q. infectoria</italic>, <italic toggle="yes">Syzygium aromaticum</italic>, and <italic toggle="yes">B. carteri</italic>. It is stated that the root of <italic toggle="yes">B. carteri</italic>, which was extracted by Methanol and H<sub>2</sub>O, exhibited great inhibitory properties against HCV (&#8805;&#8201;90% inhibition at 100&#160;&#181;g/mL) (Table <xref rid="Tab1" ref-type="table">1</xref>) (Hussein et al. <xref ref-type="bibr" rid="CR38">2000</xref>).<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Antiviral activities reported from <italic toggle="yes">Boswellia</italic> species</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"><italic toggle="yes">Boswellia</italic> species</th><th align="left" colspan="1" rowspan="1">Virus</th><th align="left" colspan="1" rowspan="1">Part used</th><th align="left" colspan="1" rowspan="1">Bioactive compound</th><th align="left" colspan="1" rowspan="1">Study design(in vitro/in vivo)</th><th align="left" colspan="1" rowspan="1">Scientific evidence</th><th align="left" colspan="1" rowspan="1">Ref</th></tr></thead><tbody><tr><td align="left" rowspan="5" colspan="1"><italic toggle="yes">B. serrata</italic></td><td align="left" colspan="1" rowspan="1">Epstein&#8211;Barr virus(EBV)</td><td align="left" colspan="1" rowspan="1">Resin (methanolic extract, n-Hexane, EtOAc, n-BuOH and H2O-soluble fraction/ 1, 10, 100&#160;mg/ml</td><td align="left" colspan="1" rowspan="1">Acetyl b-boswellic acid, Lupeolic acid, Acetyl lupeolic acid, Elemonic acid, 3a-Hydroxytirucalla-7,24-dien-21-oic acid, 3a-Acetoxytirucalla-7,24-dien-21-oic acid, 3b-Hydroxytirucalla-8,24-dien-21-oic acid</td><td align="left" colspan="1" rowspan="1">IMR-32, NB-39, and SK-N-SH and Raji cells lines</td><td align="left" colspan="1" rowspan="1">Inhibitory effects on EBV-EA, inhibit chemical carcinogenesis and cytotoxic activity on neuroblastoma cell lines</td><td align="left" colspan="1" rowspan="1">Akihisa et al. (<xref ref-type="bibr" rid="CR2">2006</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1">Chikungunya virus</td><td align="left" colspan="1" rowspan="1">Acetyl-11-keto-b-boswellic acid (AKBA)(1&#8211;25&#160;&#181;M)</td><td align="left" colspan="1" rowspan="1">Acetyl-11-keto-&#946;-boswellic acid (AKBA)</td><td align="left" colspan="1" rowspan="1">HEK 293T cells, CHIKV-E2/E1 or VSV-G pseudotyped vector</td><td align="left" colspan="1" rowspan="1">Affect the eicosanoid biosynthetic pathway and anti-inflammatory properties</td><td align="left" colspan="1" rowspan="1">Rhein et al. (<xref ref-type="bibr" rid="CR88">2016</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1">Vesicular stomatitis virus (VSV)</td><td align="left" colspan="1" rowspan="1">Acetyl-11-keto-b-boswellic acid (AKBA)(1&#8211;25&#160;&#181;M)</td><td align="left" colspan="1" rowspan="1">Acetyl-11-keto-&#946;-boswellic acid (AKBA)</td><td align="left" colspan="1" rowspan="1">HEK 293T cells, CHIKV-E2/E1 or VSV-G pseudotyped vector</td><td align="left" colspan="1" rowspan="1">Affect the eicosanoid biosynthetic pathway and anti-inflammatory properties</td><td align="left" colspan="1" rowspan="1">Rhein et al. (<xref ref-type="bibr" rid="CR88">2016</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1">Herpes simplex virus (HSV)</td><td align="left" colspan="1" rowspan="1">Methanol extract of <italic toggle="yes">B. serrata</italic> oleo-gum-resin (BSE) and &#946;-boswellic acid (BA) (0&#8211;1000&#160;&#956;g/ml)</td><td align="left" colspan="1" rowspan="1">&#946;-boswellic acid, 11-Keto-&#946;-boswellic acid, 3-O-Acetyl-11-keto-&#946;-boswellic acid</td><td align="left" colspan="1" rowspan="1">Vero cells (African green monkey kidney cells), and BALB/c mice</td><td align="left" colspan="1" rowspan="1">Inhibits HSV-1 through the modulation of NF-&#1082;B and p38 MAP kinase</td><td align="left" colspan="1" rowspan="1">Goswami et al. (<xref ref-type="bibr" rid="CR31">2018</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1">Avian infectious bronchitis virus (AIBV)</td><td align="left" colspan="1" rowspan="1">Essential oil (natural oil blend 2.5, 1.25, 0.625, 0.3125, 0.156, 0.08, 0.04, 0.01, 0.005, 0.0025 and 0.00125&#160;ml)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">Embryonated chicken eggs</td><td align="left" colspan="1" rowspan="1">Deactivate the AIBV in in vitro medium</td><td align="left" colspan="1" rowspan="1">Keri Lestari et al. (<xref ref-type="bibr" rid="CR46">2021</xref>)</td></tr><tr><td align="left" rowspan="5" colspan="1"><italic toggle="yes">B. carteri</italic></td><td align="left" colspan="1" rowspan="1">Herpes simplex virus (HSV)</td><td align="left" colspan="1" rowspan="1">Oleo-gum-resin (total acid fraction 20 and 40&#160;&#956;g/ml)</td><td align="left" colspan="1" rowspan="1">Total acid extract (acetyl-11-keto-&#946;-Boswellic acid, &#946;-Boswellic, acetyl-b-Boswellic, 11-keto-&#946;-Boswellic, 3 hydroxytirucallic acid, 3-oxo-tirucallic acid, acetyl-&#945;-boswellic acid)</td><td align="left" colspan="1" rowspan="1">Vero cells (African green monkey kidney cells)</td><td align="left" colspan="1" rowspan="1">Reduced the number of plaques virus</td><td align="left" colspan="1" rowspan="1">Badria et al. (<xref ref-type="bibr" rid="CR6">2016</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1">Influenza virus</td><td align="left" colspan="1" rowspan="1">Gum</td><td align="left" colspan="1" rowspan="1">Largely of polysaccharides</td><td align="left" colspan="1" rowspan="1">Rat</td><td align="left" colspan="1" rowspan="1">Making the pH of blood alkaline and preventing viral infection</td><td align="left" colspan="1" rowspan="1">Ali and Hashim (<xref ref-type="bibr" rid="CR4">2020</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1">Peste des petits ruminants virus (PPRV)</td><td align="left" colspan="1" rowspan="1">Gum</td><td align="left" colspan="1" rowspan="1">Largely of polysaccharides</td><td align="left" colspan="1" rowspan="1">Goats and sheep</td><td align="left" colspan="1" rowspan="1">(vaccine delivery) Delayed release time and enhanced immune response</td><td align="left" colspan="1" rowspan="1">Mumin et al. (<xref ref-type="bibr" rid="CR58">2020</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1">Newcastle disease virus (NDV)</td><td align="left" colspan="1" rowspan="1">Gum</td><td align="left" colspan="1" rowspan="1">largely of polysaccharides</td><td align="left" colspan="1" rowspan="1">Nigerian local birds</td><td align="left" colspan="1" rowspan="1">(vaccine delivery) Delayed release time and enhanced immune response</td><td align="left" colspan="1" rowspan="1">Ola et al. (<xref ref-type="bibr" rid="CR62">2021</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1">Hepatitis C virus (HCV)</td><td align="left" colspan="1" rowspan="1">Root (aqueous and methanolic extract)</td><td align="left" colspan="1" rowspan="1">&#8211;</td><td align="left" colspan="1" rowspan="1">HCV-PR</td><td align="left" colspan="1" rowspan="1">Inhibitory effects on the HCV-PR activity</td><td align="left" colspan="1" rowspan="1">Hussein et al. (<xref ref-type="bibr" rid="CR38">2000</xref>)</td></tr><tr><td align="left" rowspan="2" colspan="1"><italic toggle="yes">B. elongate</italic></td><td align="left" colspan="1" rowspan="1">Herpes simplex virus (HSV)</td><td align="left" colspan="1" rowspan="1">Bark (aqueous and methanolic extract/100, 50, 25, 12.5, 6.25, 3.1, 1.5 and 0.7&#160;&#956;g/mL)</td><td align="left" colspan="1" rowspan="1">Triterpenoids and phytosterols</td><td align="left" colspan="1" rowspan="1">MDCK (Madin&#8211;Darby canine kidney and Vero cells (African green monkey kidney cells)</td><td align="left" colspan="1" rowspan="1">Anti-HSV-1 activity with 50% inhibition concentrations 0.35&#160;&#181;g/mL</td><td align="left" colspan="1" rowspan="1">Mothana et al. (<xref ref-type="bibr" rid="CR57">2006</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1">Influenza virus A</td><td align="left" colspan="1" rowspan="1">Bark (aqueous and methanolic extract/100, 50, 25, 12.5, 6.25, 3.1, 1.5, and 0.7&#160;&#956;g/mL)</td><td align="left" colspan="1" rowspan="1">Triterpenoids and phytosterols</td><td align="left" colspan="1" rowspan="1">MDCK (Madin&#8211;Darby canine kidney and Vero cells (African green monkey kidney cells)</td><td align="left" colspan="1" rowspan="1">Anti-influenza virus type A activity with 50% inhibition concentrations 3.1&#160;&#181;g/mL</td><td align="left" colspan="1" rowspan="1">Mothana et al. (<xref ref-type="bibr" rid="CR57">2006</xref>)</td></tr><tr><td align="left" rowspan="2" colspan="1"><italic toggle="yes">B. ameero</italic></td><td align="left" colspan="1" rowspan="1">Herpes simplex virus (HSV)</td><td align="left" colspan="1" rowspan="1">Bark (aqueous and methanolic extract /100, 50, 25, 12.5, 6.25, 3.1, 1.5 and 0.7&#160;&#956;g/mL)</td><td align="left" colspan="1" rowspan="1">Triterpenoids and phytosterols</td><td align="left" colspan="1" rowspan="1">MDCK (Madin&#8211;Darby canine kidney and Vero cells (African green monkey kidney cells)</td><td align="left" colspan="1" rowspan="1">Anti-HSV-1 activity with 50% inhibition concentrations 1.5&#160;&#181;g/mL</td><td align="left" colspan="1" rowspan="1">Mothana et al. (<xref ref-type="bibr" rid="CR57">2006</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1">Influenza virus A</td><td align="left" colspan="1" rowspan="1">Bark (aqueous and methanolic extract /100, 50, 25, 12.5, 6.25, 3.1, 1.5 and 0.7&#160;&#956;g/mL)</td><td align="left" colspan="1" rowspan="1">Triterpenoids and phytosterols</td><td align="left" colspan="1" rowspan="1">MDCK (Madin&#8211;Darby canine kidney and Vero cells (African green monkey kidney cells)</td><td align="left" colspan="1" rowspan="1">Anti-influenza virus type A activity with 50% inhibition concentrations 12.5&#160;&#181;g/Ml</td><td align="left" colspan="1" rowspan="1">Mothana et al. (<xref ref-type="bibr" rid="CR57">2006</xref>)</td></tr><tr><td align="left" rowspan="2" colspan="1"><italic toggle="yes">B. dalzielii</italic></td><td align="left" rowspan="2" colspan="1">Newcastle disease virus (NDV)</td><td align="left" colspan="1" rowspan="1">Stem bark (methanol extract and the three fractions (ethyl acetate, n-butanol and aqueous/ 200, 100, 50, 25, 12.5, 6.25 and 3.125&#160;mg/ml)</td><td align="left" colspan="1" rowspan="1">Tannins, saponin, flavonoids, terpenoids and steroids</td><td align="left" colspan="1" rowspan="1">Embryonated chicken eggs</td><td align="left" colspan="1" rowspan="1">Methanol stem bark extract of <italic toggle="yes">B. dalzielii</italic> have the most anti-NDV activity than the fractions</td><td align="left" colspan="1" rowspan="1">Ohemu et al. (<xref ref-type="bibr" rid="CR61">2020</xref>)</td></tr><tr><td align="left" colspan="1" rowspan="1">Stem bark (methanol extract, 250, 200, 150, 100,50, 25, and 12.5&#160;mg/ml)</td><td align="left" colspan="1" rowspan="1">Carbohydrates, steroids, triterpenes, cardiac glycosides, tannins and flavonoids and absence of alkaloid</td><td align="left" colspan="1" rowspan="1">Embryonated chicken egg</td><td align="left" colspan="1" rowspan="1">Alive of the embryo and complete clearance of the virus from the allantoic fluid</td><td align="left" colspan="1" rowspan="1">Ohemu et al. (<xref ref-type="bibr" rid="CR60">2018</xref>)</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec7"><title>Chikungunya virus (CHIKV)</title><p id="Par10">Being the alphavirus of Togaviridae family, Chikungunya virus (CHIKV) is a single-stranded RNA virus with positive polarity that is transferred to humans through mosquito bites (Caglioti et al. <xref ref-type="bibr" rid="CR14">2013</xref>). The common symptoms of this infection include headache, fever, rash, joint swelling, muscle pain, fatigue, and nausea. Currently, there are no vaccines or special antiviral drugs available for CHIKV infection, while experts have been trying different approaches to reduce the symptoms (Simon et al. <xref ref-type="bibr" rid="CR80">2011</xref>). Von Rhein et al. investigated the antiviral effects of acetyl-11-keto-&#946;-boswellic acid or curcumin against CHIKV, which is one of the most important bioactive compounds of <italic toggle="yes">B. serrata</italic> gum resin. Their results confirmed the ability of acetyl-11-keto-&#946;-boswellic acid and curcumin in inhibiting the viral infection and proved their efficient blockage against the gene transfer of CHIKV Env or VSV-G-pseudotyped lentiviral vectors into HEK 293T cells (Table <xref rid="Tab1" ref-type="table">1</xref>) (Rhein et al. <xref ref-type="bibr" rid="CR88">2016</xref>).</p></sec><sec id="Sec8"><title>Herpes simplex virus (HSV)</title><p id="Par11">Herpes simplex virus (HSV) is a member of herpesviridae family that is enveloped with double-stranded DNA and cause infections and diseases in animals and humans (Corey and Spear <xref ref-type="bibr" rid="CR19">1986</xref>). Herpes simplex virus (HSV) types 1 and 2 (HSV-1 and HSV-2, respectively) are the two serotypes of Herpesviridae family. The infection of HSV-1 is mainly oral and involves the lips, gums, or throat. It mostly infects the genital mucosa and stands as a risk factor for sexually transmitted diseases such as HIV infection (Buxbaum et al. <xref ref-type="bibr" rid="CR13">2003</xref>). There are some antiviral medicines available for the treatment of HSV infection including acyclovir, famciclovir, penciclovir, and valacyclovir, however, the clinical process is often disturbed by drug resistance (Pasternak and Hviid <xref ref-type="bibr" rid="CR66">2010</xref>). The work of Goswami et al. indicated the ability of <italic toggle="yes">B. serrata</italic> oleo-gum-resin, as well as one of its major constituent known as &#946;-boswellic acid, to effectively inhibit Herpes Simplex virus 1(HSV) infection (effective concentration (EC<sub>50</sub>): 5.2&#8211;6.2 and 12.1&#8211;14.63&#160;&#956;g/ml, respectively) through the modulation of NF-&#954;B that is essential for virus replication and p38MAPK pathway. In addition, their observations mentioned the considerable down-regulation of NF-&#954;B, and p38 MAP-kinase activation along with the reduced expression of&#160;tumor necrosis factor &#945; (TNF-&#945;), Interleukin 1&#946; (IL-1&#946;), and interleukin-6)IL-6(that are involved in the scheming process of NF-&#954;B signaling (Goswami et al. <xref ref-type="bibr" rid="CR31">2018</xref>). In another study, Mothana et al. evaluated the antiviral activity of 25 different plant species extracts, used in traditional Yemeni medicine, against influenza virus type A and herpes simplex virus type 1. Among their samples, the methanol extract of <italic toggle="yes">B. elongata</italic> was one of the most effective drugs against herpes simplex. In addition, they proved the strong anti-bacterial effects of aqueous and methanol extracts of <italic toggle="yes">B. elongata</italic> as well (Mothana et al. <xref ref-type="bibr" rid="CR57">2006</xref>). In another work, Badria et al. investigated the anti-herpes activity of oleo-gum-resin of frankincense (<italic toggle="yes">B. carteri</italic> Bird wood). In comparison to the nine isolated compounds from oleo-gum-resin, their results confirmed the inducement of strongest impact by the total extract against the herpes simplex type I virus (Table <xref rid="Tab1" ref-type="table">1</xref>) (Badria et al. <xref ref-type="bibr" rid="CR6">2016</xref>).</p></sec><sec id="Sec9"><title>Epstein&#8211;Barr virus (EBV)</title><p id="Par12">Epstein&#8211;Barr virus (EBV) is an enveloped virus that contains a DNA core with a 184-kbp long member of herpes virus family. This infection frequently occurs in adolescents with the symptoms of inflamed throat, sore throat, enlarged spleen, swollen liver, fatigue, fever, and rash. Generally, EBV spreads through body fluids, blood transfusion, and sexual intercourse. There are no vaccines or any specific treatments available for the treatment of infection (Dunmire et al. <xref ref-type="bibr" rid="CR25">2018</xref>; Feng et al. <xref ref-type="bibr" rid="CR28">2004</xref>). Akihisa et al. extracted different compounds from the resin of <italic toggle="yes">B. carteri</italic> to study their antiviral activity against Epstein&#8211;Barr virus<italic toggle="yes">.</italic> Some of these compounds caused strong cytotoxic effects with the IC<sub>50</sub> value of 4.1&#8211;82.4&#160;&#181;M against human neuroblastoma cells and displayed potent inhibitory impacts on EBV-EA induction. Their work proposed the potential benefits of using the triterpene acid ingredients of methanolic extract of <italic toggle="yes">B. carteri</italic> resin for preventing the inducement of chemical carcinogenesis (Table <xref rid="Tab1" ref-type="table">1</xref>) (Akihisa et al. <xref ref-type="bibr" rid="CR2">2006</xref>).</p></sec><sec id="Sec10"><title>Influenza virus</title><p id="Par13">Influenza virus belongs to the Orthomyxoviridae family and contains single-stranded and negative-sense RNA. Since ACE2 functions as a receptor for cellular entry in this virus, it seems that its inhibition may be effective in blocking its entrance (Cottey et al. <xref ref-type="bibr" rid="CR21">2001</xref>; Chang et al. <xref ref-type="bibr" rid="CR17">2021</xref>). In conformity to previous reports, Mothana et al., studied the antiviral effects of different plant extracts used in traditional Yemeni medicine. Their outcomes indicated that the aqueous extracts of <italic toggle="yes">B. ameero,</italic> and <italic toggle="yes">B. elongate</italic> and methanol extract of <italic toggle="yes">B. elongate</italic> caused the strongest impacts against influenza virus A. In addition, they observed a decrease in the nucleic acid synthesis of influenza virus upon their exposure to the extracts of <italic toggle="yes">B. ameero</italic> (Table <xref rid="Tab1" ref-type="table">1</xref>) (Mothana et al. <xref ref-type="bibr" rid="CR57">2006</xref>). Another study assessed the outcomes of diet therapy for inhibiting viral infections through the oral and inhalation usage of essential oils, Saccharomyces cerevisiae, <italic toggle="yes">B. Carteri,</italic> and Zinc. This treatment was able to prevent influenza infection and increase the number of leukocytes in the blood samples of animals through an appropriate diet. <italic toggle="yes">B. Carteri</italic> is capable of effectively strengthening the immune system, producing the alkaline pH of blood, and preventing viral infections (Table <xref rid="Tab1" ref-type="table">1</xref>) (Ali and Hashim <xref ref-type="bibr" rid="CR4">2020</xref>).</p></sec><sec id="Sec11"><title>Vesicular stomatitis virus (VSV)</title><p id="Par14">As a member of Rhabdoviridae family, Vesicular stomatitis virus (VSV) is a negative-strand RNA virus that causes infections in humans and animals. Human infections are commonly associated with exposure to infected animals. Insect bites commonly induce VSV infection in animals such as cattle, swine, and horses, which can be diagnosed by the symptoms of foot and mouth disorders (Garbutt et al. <xref ref-type="bibr" rid="CR30">2004</xref>; Brown <xref ref-type="bibr" rid="CR12">1987</xref>). According to the study of von Rhein et al., VSV vector particles and the viral infections of 293T cells were considerably inhibited by the exertion of <italic toggle="yes">B. serrata</italic> gum-resin extract and curcumin. According to related experiments, the main mechanism of viral inhibition by Acetyl-11-keto-b-boswellic acid implicates the blockage of virus entry into the target cells (Table <xref rid="Tab1" ref-type="table">1</xref>) (Rhein et al. <xref ref-type="bibr" rid="CR88">2016</xref>).</p></sec><sec id="Sec12"><title>Newcastle disease virus (NDV)</title><p id="Par15">Newcastle disease virus (NDV) belongs to the Paramyxoviridae family that has proved its importance in poultry industry by causing infections in domestic poultry. NDV is a single strand of negative-sense RNA virus that is extremely transmissible and has remained as the main poultry disease (Ganar et al. <xref ref-type="bibr" rid="CR29">2014</xref>; Munir et al. <xref ref-type="bibr" rid="CR59">2012</xref>). In the work of Ohemu et al., the stem bark of <italic toggle="yes">B. dalzielii</italic> and <italic toggle="yes">Enantia chlorantha</italic> methanol extracts were used to study their impact on the virus of Newcastle disease (ND) through an <italic toggle="yes">in ovo</italic> assay on embryonated eggs. Preliminary phytochemical screening recorded the presence of carbohydrates, steroids, triterpenes, cardiac glycosides, tannins, and flavonoids in the stem bark extract of <italic toggle="yes">B. dalzielii</italic>. Interestingly, <italic toggle="yes">this product</italic> exhibited remarkable antiviral effects against NDV while the embryos were observed to survive throughout every studied concentration (Ohemu et al. <xref ref-type="bibr" rid="CR60">2018</xref>). In another report, Ohemu et al. investigated the impact of using fractions and extracts of <italic toggle="yes">B. dalzielii</italic> on NDV through the application of chicken embryonated eggs. The performance of solvent&#8211;solvent fractionation for the methanol extract of <italic toggle="yes">B. dalzielii</italic> required the application of solvents with various polarity, while four fractions were generated that included hexane, ethyl acetate, n-butanol, and aqueous. Tannins, flavonoids, saponin, terpenoids, and steroids were detected in the extract of stem bark and fractions of <italic toggle="yes">B. dalzielii.</italic> In comparison to the results of other fractions, the methanol stem bark extract of <italic toggle="yes">B. dalzielii</italic> displayed a considerably stronger anti-NDV activity (Ohemu et al. <xref ref-type="bibr" rid="CR61">2020</xref>).</p></sec><sec id="Sec13"><title>Avian infectious bronchitis virus (AIBV)</title><p id="Par16">As a member of Coronaviridae family, Avian infectious bronchitis virus (AIBV) was observed to cause diseases only in chickens, while containing many antigenic types that differ in various regions. As a positive-sense single-stranded RNA virus, AIBV implicates the inducement of nephropathogenic infection and respiratory disorders. In addition, depression, ruffled feathers, wet droppings, greater water intake, and death are included among the other reported symptoms. Although wide vaccination was attempted as a solution to control the prevalence of AIBV, however, this procedure was faced with the challenging obstacle of resistance. So far, science has been incapable of developing any effective drugs or vaccines against this virus due to its highly mutable nature (Ignjatovi&#263; and Sapats <xref ref-type="bibr" rid="CR5">2000</xref>; Bande et al. <xref ref-type="bibr" rid="CR7">2015</xref>). Lestari et al. exerted an allantoic fluid medium to investigate the effects of natural oil blend of <italic toggle="yes">B. serrata</italic>, <italic toggle="yes">Gardenia jasminoides</italic>, <italic toggle="yes">Commiphora myrrha</italic>, <italic toggle="yes">Daucus carota</italic>, and <italic toggle="yes">Foeniculum vulgare</italic> on Avian Infectious Bronchitis Virus H120 strain (AIBV H120). To counteract the lethal dosage of virus, various concentrations of natural oil blend (NOB) were inoculated into the allantoic fluid. Although the embryos of positive control group were annihilated, yet they reported the survival of treated samples with natural oil blend and revealed the capability of essential oil Blend in performing the in vitro inhibition of AIBV H120 (Table <xref rid="Tab1" ref-type="table">1</xref>) (Keri Lestari et al. <xref ref-type="bibr" rid="CR46">2021</xref>).</p></sec></sec><sec id="Sec14"><title>Use <italic toggle="yes">Boswellia</italic> species in vaccine formulations</title><p id="Par17">Natural gums and mucilage can be used in the designs of nasal drug or vaccine delivery due to their mucoadhesive properties. Next to the ability of mucosa in covering the nasal cavity, the applied drug/vaccine can be directly transferred to the systemic blood circulation without facing the hepatic first pass effect and intestinal metabolism. However, oral vaccines can provide certain advantages such as simple usage, low cost, and mucosal immune responses (Smart et al. <xref ref-type="bibr" rid="CR83">1984</xref>; Peppas and Sahlin <xref ref-type="bibr" rid="CR67">1996</xref>; Emikpe et al. <xref ref-type="bibr" rid="CR27">2016</xref>; Yonesi and Kamrani <xref ref-type="bibr" rid="CR89">2019</xref>). In addition, natural gums proved to be an appropriate choice for delaying the drug release, which has led to the growing interest in the application of these polymers in sustained drug and vaccine delivery (Bhosale et al. <xref ref-type="bibr" rid="CR10">2014</xref>; Manjula et al. <xref ref-type="bibr" rid="CR54">2014</xref>; Cox et al. <xref ref-type="bibr" rid="CR22">1999</xref>). In this section, a discussion is presented on the role of <italic toggle="yes">Boswellia</italic> gum in the preparation and formulation of various antiviral vaccines.</p><sec id="Sec15"><title>Vaccine against Newcastle disease virus (NDV)</title><p id="Par18">As described in Section&#160;5.7., NDV is a significant avian virus with the ability to cause fatal infection in many species of birds. However, the applications of NDV vaccines were effective in reducing the cases of this disease (Sinkovics and Horvath <xref ref-type="bibr" rid="CR82">2000</xref>). Ola et al. reported an evaluation on the role of microbeads throughout the vaccine delivery of Newcastle Disease (ND) in chickens. Vaccine-containing beads were produced by the ionotropic-gelation technique that implicates the application of aluminum sulfate, sodium alginate, and <italic toggle="yes">B. carteri</italic> gum. This study involved 60 local birds of 8-weeks-old, which were divided into four groups (15 birds per group). The vaccination was orally administered into the samples as they reached 65&#160;days old. Accordingly, group A was treated with vaccine-loaded bead (VLB), group B received the treatment of vaccine alone (VA), group C was treated with unloaded bead (UB), and group D did not receive any beads or vaccines (NBNV/negative control). The application of microbeaded-vaccine (group A) resulted in increasing the time of vaccine release and prolonged the systemic immune responses of birds (Table <xref rid="Tab1" ref-type="table">1</xref>) (Ola et al. <xref ref-type="bibr" rid="CR62">2021</xref>).</p></sec><sec id="Sec16"><title>Vaccine against Peste des petits ruminants virus (PPRV)</title><p id="Par19">Peste des petits ruminants virus (PPRV) is a fatal viral disease of domestic and wild small ruminants that can be diagnosed by the common symptoms of fever, pneumonia, cough, diarrhea, respiratory inflammation, ocular discharges, oral necrosis, and digestive tracts (Kumar et al. <xref ref-type="bibr" rid="CR51">2014</xref>; Kwiatek et al. <xref ref-type="bibr" rid="CR52">2007</xref>). Mumin et al. reported the preparation of gums from <italic toggle="yes">B. frereana</italic>, <italic toggle="yes">B. carteri</italic>, and <italic toggle="yes">Commiphora myrrha</italic>, as well as their investigation results on their mucoadhesive feature and immunomodulatory effects on intranasal vaccination against PPR. This study involved the participation of forty-eight animal samples (24 goats and 24 sheep) that were divided into eight groups (3 goats and 3 sheep in each group). Then, they prepared two ratios (1:1, 1:2) of gum-vaccine combinations and performed nasal vaccination. On the days 14, 28, 42, and 56 post vaccination, the existing antibody against PPRV was measured by the utilization of H-based PPR bELISA. The best inhibition was observed from the case of <italic toggle="yes">B. carteri</italic>-vaccine combination group at a ratio of 1:1, which displayed a similar antibody titer to that of a subcutaneous route. Therefore, this method can be suggested as a safe and noninvasive alternative for PPR vaccination (Table <xref rid="Tab1" ref-type="table">1</xref>) (Mumin et al. <xref ref-type="bibr" rid="CR58">2020</xref>).</p></sec></sec><sec id="Sec17"><title>SARS-CoV-2</title><sec id="Sec18"><title>Overview of SARS-CoV-2</title><p id="Par20">Coronavirus disease (COVID-19) is a novel viral illness generated from the SARS-CoV-2 virus and has caused the death of millions of people worldwide since the start of its pandemic that was around two years ago. Despite the presence of available antiviral drugs, there is a continuous worldwide effort to control and limit this disease (Organization <xref ref-type="bibr" rid="CR63">2020</xref>; Rothan and Byrareddy <xref ref-type="bibr" rid="CR72">2020</xref>). The major transmission routes of COVID-19 include the composed droplets and aerosol particles upon coughing and speaking, as well as making direct contact with an infected patient. Dry cough, loss of taste or smell, running nose, tiredness, high fever, and body ache are the common symptoms of this illness (Pullen et al. <xref ref-type="bibr" rid="CR70">2020</xref>). Coronaviruses (CoVs) are a very diverse family of enveloped positive-sense single-stranded RNA viruses. Alpha-coronavirus, Beta-coronavirus, Gamma-coronavirus, and Delta-coronavirus are the subfamilies of Orthocoronavirinae (Pal et al. <xref ref-type="bibr" rid="CR64">2020</xref>). The cytokine storm process of COVID-19 is a crucial factor that begins with the cellular entry of SARS-CoV-2 by cellular ACE2 receptor and proceeds with the provoking of immune response through the production of interferon (IFN), granulocyte&#8211;macrophage colony-stimulating factor (GM-CSF) and TNF-&#945;, and interleukin-6 (IL-6), as well as the infiltration of macrophages and neutrophils into the lung tissue (Zhou et al. <xref ref-type="bibr" rid="CR90">2020</xref>). Other studies reported the observance of a larger amount of IL-2, IL-6, IL-7, IL-10, IP-10, MCP-1, TNF-&#945; in patients with severe COVID-19 infection, while facing the exceeding counts of neutrophil, which is in contrast to that of the mild patients (Hu et al. <xref ref-type="bibr" rid="CR36">2021</xref>).</p></sec><sec id="Sec19"><title>Evaluating the efficiency of Boswellia species against SARS-CoV-2 by molecular docking</title><p id="Par21">Computational methods were broadly exerted for discovering novel drugs throughout the last decade. During the course of SARS-CoV-2 infection, in silico analysis and molecular docking studies were immensely contributed to the topics of drug evolution action and potential inhibitors against this illness. Virtual screening were developed for the wide database of active compounds or known drugs through the performance of docking procedures against SARS-CoV-2. The candidate drugs were able to cause a great inhibitory effect on SARS-CoV-2 and also reduce the burden of in vitro and clinical experiments (Heiat et al. <xref ref-type="bibr" rid="CR35">2021</xref>). The in silico study of Kadhim et al. involved an evaluation on the inhibitory effects of boswellic acid and beta-boswellic acid against SARS-CoV-2 virus (Kadhim et al. <xref ref-type="bibr" rid="CR44">2021</xref>; Caliebe et al. <xref ref-type="bibr" rid="CR15">2021</xref>). Considering how the reproduction of this virus depends on the binding of its spikes to the cell receptors, the docking studies of this survey were conducted using Molecular Graphic Laboratory (MGL) tools and AutoDock Vina application to gather data on the interaction of virus spikes and alpha-Boswellic acid or beta-Boswellic acid, which resulted in indicating the existing of a high affinity among them and also confirmed the safety of using large doses of these compounds in humans due to their LC50 values (Kadhim et al. <xref ref-type="bibr" rid="CR44">2021</xref>). In another study, molecular docking and molecular dynamics simulations were used to screen a medicinal plant library for detecting potential compounds against COVID-19. As a result, Qamar et al., introduced nine phytochemical ingredients with potential inhibitory effects on COVID-19 (ul Qamar MT et al. <xref ref-type="bibr" rid="CR85">2020</xref>). Furthermore, Heiat et al. reviewed the available articles on various aspects of COVID-19, including the prevention, diagnosis, and treatment areas, while mentioning the studies that used computational methods and computer modeling approaches such as molecular dynamics (MD) simulation technique. Their conclusion emphasized the necessity of applying both traditional and modern sciences for designing combating approaches towards COVID-19 (Heiat et al. <xref ref-type="bibr" rid="CR35">2021</xref>). In another study, Roy et al. also evaluated the potential of existing bioactive compounds in <italic toggle="yes">B. serrata</italic> against the Mpro enzyme of SARS-CoV-2 through the application of computational techniques. Five compounds, including Euphane, Ursane, &#945;-Amyrin, Phytosterol, and 2,3-Dihydroxyurs-12-en-28-oic, exhibited maximum binding affinities with the binding energies of&#8201;&#8722;&#8201;10.47&#160;kcal/mol,&#8201;&#8722;&#8201;10.41&#160;kcal/mol,&#8201;&#8722;&#8201;9.99&#160;kcal/mol,&#8201;&#8722;&#8201;9.94&#160;kcal/mol, and&#8201;&#8722;&#8201;9.72&#160;kcal/mol, respectively (Roy and Menon <xref ref-type="bibr" rid="CR73">2021</xref>).</p></sec><sec id="Sec20"><title>Anti-inflammatory and anti-bacterial effects of Boswellia species</title><p id="Par22">The anti-inflammatory and anti-bacterial properties of <italic toggle="yes">Boswellia</italic> species could be considered as a treatment capacity against the symptoms of SARS-CoV-2. Chib et al. evaluated the anti-inflammatory potential of isolated compounds from <italic toggle="yes">B. ovalifoliolata</italic>. Two compounds (3a-hydroxy-tirucall-8,24-dien-21-oic acid and one type of triterpenoid) were taken from the ethanolic extract of oleo-gum-resin of <italic toggle="yes">B. ovalifoliolata</italic>, which were able to remarkably prevent the TNF-&#945; expression in murine neutrophils and cause a decrease in the production of interleukin IL-6, IL-8, and nitric oxide. Furthermore, there are reports on the inhibition of 5-lipoxygenase enzyme and leukotriene by acetyl-11-keto-&#946;-boswellic acid that is a pentacyclic triterpene in the Gum resin extracts of <italic toggle="yes">B. serrata</italic> (Chib et al. <xref ref-type="bibr" rid="CR18">2014</xref>). According to other studies, <italic toggle="yes">B. serrata</italic> can enhance the clinical results of ischaemic stroke and conventional therapies due to the anti-inflammatory effect of Boswellic acids. This substance can inhibit certain pro-inflammatory cytokines such as TNF-&#945;, interleukin-1&#946; (IL-1&#946;), interferon-gamma (IFN-&#947;), and 5-lipoxygenase (5-LOX), which would lead to the blockage of inflammatory mediators such as leukotrienes. Another study displayed the superior enrichment of Aflapin&#174; by the acetyl-11-keto-&#946;-boswellic acid extract of <italic toggle="yes">B. serrata</italic> when compared to that of 5-Loxin&#174;, which is capable of providing a better protection from the induced proteolytic degradation by inflammatory and facilitating the recovery of articular cartilage damage (Sengupta et al. <xref ref-type="bibr" rid="CR76">2010</xref>). The antimicrobial activity of resin <italic toggle="yes">B. serrata</italic> was evaluated and compared with Ciprofloxacin in the concentrations of 25, 50, 75, and 100&#160;mg/ml against eight Gram positive and negative bacteria (Ismail et al. <xref ref-type="bibr" rid="CR39">2014</xref>).</p></sec><sec id="Sec21"><title>Clinical trials of Boswellia species</title><p id="Par23">A lot of clinical trials have been performed on <italic toggle="yes">Boswellia</italic> species (Kimmatkar et al. <xref ref-type="bibr" rid="CR47">2003</xref>). Boswellia extracts displayed some promise for the treatment of rheumatoid arthritis, asthma, knee osteoarthritis, collagenous colitis, and Crohn&#8217;s disease (Karimifar et al. <xref ref-type="bibr" rid="CR45">2017</xref>). Kulkarni et al. presented a report on the clinical trials of herbomineral formulation for rheumatoid arthritis treatment, which included rhizomes of <italic toggle="yes">Curcuma longa</italic>, roots of <italic toggle="yes">Withania somnifera</italic>, the stem of <italic toggle="yes">B. serrata</italic>, and a zinc complex (Kulkarni et al. <xref ref-type="bibr" rid="CR50">1991</xref>). Another study showed that oral supplementation of <italic toggle="yes">B. serrata</italic> extract containing 3&#8208;acetyl&#8208;11&#8208;keto&#8208;&#946;&#8208;boswellic acid and &#946;&#8208;boswellic acid remarkably raised physical function by decreasing pain and stiffness compared with placebo. Additionally, radiographic assessment displayed that <italic toggle="yes">B. serrata</italic> extract remarkably increased between the knee joints and decreased osteophytes formation compared with the placebo. More importantly, <italic toggle="yes">B. serrata</italic> extract treatment comprising 30% 3&#8208;acetyl&#8208;11&#8208;keto&#8208;&#946;&#8208;boswellic acid and &#946;&#8208;boswellic acid significantly decreased high&#8208;sensitive C&#8208;reactive protein values compared with the placebo group (Majeed et al. <xref ref-type="bibr" rid="CR53">2019</xref>). Barzin Tond et al. examined the effects of Infawell<sup>&#174;</sup> syrup, a Boswellia extract formulation enriched for boswellic acids, (10&#160;ml of Infawell<sup>&#174;</sup> syrup thrice daily (30&#160;ml/day for 14&#160;days) in patients with moderate COVID-19. Their outcomes indicated the inducement of a reduction in the percentage of neutrophils, neutrophil-to-lymphocyte ratio levels, CRP, LDH, IL&#8211;6, and TNF&#8211;&#945; levels, while heightening the percentage of lymphocytes and improving the clinical symptoms such as dyspnea, cough, myalgia, headache, and gustatory dysfunction and olfactory (Barzin Tond et al. <xref ref-type="bibr" rid="CR8">2022</xref>). In another study, forty female survivors of COVID-19, who were experiencing low energy levels after recovery, were treated by aromatherapy with Longevity&#8482; (twice daily for 14&#160;days) essential oils that were extracted from <italic toggle="yes">Thymus vulgaris</italic>, <italic toggle="yes">Citrus sinensis</italic>, <italic toggle="yes">Eugenia caryophyllus</italic>, and <italic toggle="yes">B. carteri</italic>. In conformity to the results, aromatherapy blend can notably enhance the energy levels of women who were experiencing fatigue after recovering from COVID-19 (Hawkins et al. <xref ref-type="bibr" rid="CR34">2022</xref>).</p></sec></sec><sec id="Sec22"><title>Conclusion</title><p id="Par24">In this review, we discussed the antiviral actions of <italic toggle="yes">Boswellia</italic> species that may be capable of displaying potential therapeutic activity against COVID-19, considering how different parts of this plant, especially oleo-gum-resin, is exerted in the treatment of several viral diseases. Besides, next to being implicated in the intranasal vaccine of animal viral diseases, gum-resin can increase the time of release. According to common knowledge, <italic toggle="yes">Boswellia</italic> species can display anti-inflammatory, antimicrobial, anti-asthmatic, antioxidant, antifibrotic, and anti-platelet activities, which consequently confirms its stance as a potential candidate for the treatment of COVID-19 symptoms. However, a vast range of clinical studies is required to estimate the accurate potential of antiviral <italic toggle="yes">Boswellia</italic> species to act as a leading approach towards the discovery and design of appropriate drugs.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors are thankful to Mashhad University of Medical Sciences (Mashhad, Iran).</p></ack><notes notes-type="funding-information"><title>Funding</title><p>The authors have not disclosed any funding.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Enquiries about data availability should be directed to the authors.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par25">The authors declare that they have no conflict of interest.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adake</surname><given-names>P</given-names></name><name name-style="western"><surname>Chandrashekar</surname><given-names>R</given-names></name><name name-style="western"><surname>Rao</surname><given-names>S</given-names></name></person-group><article-title>Potentiating antidepressant action of Boswellia serrata in acute models of depression: a preclinical study</article-title><source>Indo Am J Pharm Res</source><year>2013</year><volume>3</volume><fpage>4407</fpage><lpage>4412</lpage></element-citation></ref><ref id="CR2"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akihisa</surname><given-names>T</given-names></name><name name-style="western"><surname>Tabata</surname><given-names>K</given-names></name><name name-style="western"><surname>Banno</surname><given-names>N</given-names></name><name name-style="western"><surname>Tokuda</surname><given-names>H</given-names></name><name name-style="western"><surname>Nishihara</surname><given-names>R</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Cancer chemopreventive effects and cytotoxic activities of the triterpene acids from the resin of Boswellia carteri</article-title><source>Biol Pharm Bull</source><year>2006</year><volume>29</volume><issue>9</issue><fpage>1976</fpage><lpage>1979</lpage><pub-id pub-id-type="doi">10.1248/bpb.29.1976</pub-id><pub-id pub-id-type="pmid">16946522</pub-id></element-citation></ref><ref id="CR3"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aldahlawi</surname><given-names>AM</given-names></name><name name-style="western"><surname>Alzahrani</surname><given-names>AT</given-names></name><name name-style="western"><surname>Elshal</surname><given-names>MF</given-names></name></person-group><article-title>Evaluation of immunomodulatory effects of Boswellia sacra essential oil on T-cells and dendritic cells</article-title><source>BMC Complementary Med Ther</source><year>2020</year><volume>20</volume><issue>1</issue><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12906-020-03146-5</pub-id><pub-id pub-id-type="pmcid">PMC7678202</pub-id><pub-id pub-id-type="pmid">33213426</pub-id></element-citation></ref><ref id="CR4"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ali</surname><given-names>WA</given-names></name><name name-style="western"><surname>Hashim</surname><given-names>HR</given-names></name></person-group><article-title>Inhibit of the virus infections by using aromatic oils, saccharomyces cerevisiae, Boswellia carterii and zinc</article-title><source>Syst Rev Pharm</source><year>2020</year><volume>11</volume><issue>4</issue><fpage>561</fpage><lpage>569</lpage></element-citation></ref><ref id="CR6"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Badria</surname><given-names>FA</given-names></name><name name-style="western"><surname>Abu-Karam</surname><given-names>M</given-names></name><name name-style="western"><surname>Mikhaeil</surname><given-names>BR</given-names></name><name name-style="western"><surname>Maatooq</surname><given-names>GT</given-names></name><name name-style="western"><surname>Amer</surname><given-names>M</given-names></name></person-group><article-title>Anti-herpes activity of isolated compounds from frankincense</article-title><source>Biosci Biotechnol Res Asia</source><year>2016</year><volume>1</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage></element-citation></ref><ref id="CR7"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bande</surname><given-names>F</given-names></name><name name-style="western"><surname>Arshad</surname><given-names>SS</given-names></name><name name-style="western"><surname>Hair Bejo</surname><given-names>M</given-names></name><name name-style="western"><surname>Moeini</surname><given-names>H</given-names></name><name name-style="western"><surname>Omar</surname><given-names>AR</given-names></name></person-group><article-title>Progress and challenges toward the development of vaccines against avian infectious bronchitis</article-title><source>J Immunol Res</source><year>2015</year><volume>2015</volume><fpage>424860</fpage><lpage>424872</lpage><pub-id pub-id-type="doi">10.1155/2015/424860</pub-id><pub-id pub-id-type="pmid">25954763</pub-id><pub-id pub-id-type="pmcid">PMC4411447</pub-id></element-citation></ref><ref id="CR8"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barzin Tond</surname><given-names>S</given-names></name><name name-style="western"><surname>Balenci</surname><given-names>L</given-names></name><name name-style="western"><surname>Khajavirad</surname><given-names>N</given-names></name><name name-style="western"><surname>Salehi</surname><given-names>M</given-names></name><name name-style="western"><surname>Tafakhori</surname><given-names>A</given-names></name><name name-style="western"><surname>Shahmohammadi</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Inflawell&#174; improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial</article-title><source>Inflammopharmacology</source><year>2022</year><volume>30</volume><issue>2</issue><fpage>465</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1007/s10787-022-00928-w</pub-id><pub-id pub-id-type="pmid">35201518</pub-id><pub-id pub-id-type="pmcid">PMC8867130</pub-id></element-citation></ref><ref id="CR9"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Behravan</surname><given-names>J</given-names></name><name name-style="western"><surname>Salmasi</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ramezani</surname><given-names>M</given-names></name><name name-style="western"><surname>Sabeti</surname><given-names>NZ</given-names></name></person-group><article-title>Euphorbia microsciadia percolation and Soxhlet extracts exhibit antiviral activity</article-title><source>Clin Biochem</source><year>2011</year><volume>13</volume><issue>44</issue><fpage>S325</fpage><pub-id pub-id-type="doi">10.1016/j.clinbiochem.2011.08.801</pub-id></element-citation></ref><ref id="CR10"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhosale</surname><given-names>RR</given-names></name><name name-style="western"><surname>Osmani</surname><given-names>RAM</given-names></name><name name-style="western"><surname>Moin</surname><given-names>A</given-names></name></person-group><article-title>Natural gums and mucilages: a review on multifaceted excipients in pharmaceutical science and research</article-title><source>Int J Pharmacogn Phytochem Res</source><year>2014</year><volume>15</volume><issue>4</issue><fpage>901</fpage><lpage>912</lpage></element-citation></ref><ref id="CR11"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bhushan</surname><given-names>S</given-names></name><name name-style="western"><surname>Kakkar</surname><given-names>V</given-names></name><name name-style="western"><surname>Pal</surname><given-names>HC</given-names></name><name name-style="western"><surname>Guru</surname><given-names>SK</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>A</given-names></name><name name-style="western"><surname>Mondhe</surname><given-names>D</given-names></name><etal/></person-group><article-title>Enhanced anticancer potential of encapsulated solid lipid nanoparticles of TPD: a novel triterpenediol from Boswellia serrata</article-title><source>Mol Pharm</source><year>2013</year><volume>10</volume><issue>1</issue><fpage>225</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1021/mp300385m</pub-id><pub-id pub-id-type="pmid">23237302</pub-id></element-citation></ref><ref id="CR12"><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>F</given-names></name></person-group><source>The family Rhabdoviridae. The rhabdoviruses</source><year>1987</year><publisher-loc>Boston</publisher-loc><publisher-name>Springer</publisher-name><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id="CR13"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buxbaum</surname><given-names>S</given-names></name><name name-style="western"><surname>Geers</surname><given-names>M</given-names></name><name name-style="western"><surname>Gross</surname><given-names>G</given-names></name><name name-style="western"><surname>Sch&#246;fer</surname><given-names>H</given-names></name><name name-style="western"><surname>Rabenau</surname><given-names>H</given-names></name><name name-style="western"><surname>Doerr</surname><given-names>H</given-names></name></person-group><article-title>Epidemiology of herpes simplex virus types 1 and 2 in Germany: what has changed?</article-title><source>Med Microbiol Immunol</source><year>2003</year><volume>192</volume><issue>3</issue><fpage>177</fpage><lpage>181</lpage><pub-id pub-id-type="doi">10.1007/s00430-003-0183-0</pub-id><pub-id pub-id-type="pmid">12761673</pub-id></element-citation></ref><ref id="CR14"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caglioti</surname><given-names>C</given-names></name><name name-style="western"><surname>Lalle</surname><given-names>E</given-names></name><name name-style="western"><surname>Castilletti</surname><given-names>C</given-names></name><name name-style="western"><surname>Carletti</surname><given-names>F</given-names></name><name name-style="western"><surname>Capobianchi</surname><given-names>MR</given-names></name><name name-style="western"><surname>Bordi</surname><given-names>L</given-names></name></person-group><article-title>Chikungunya virus infection: an overview</article-title><source>New Microbiol</source><year>2013</year><volume>36</volume><issue>3</issue><fpage>211</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">23912863</pub-id></element-citation></ref><ref id="CR15"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caliebe</surname><given-names>RH</given-names></name><name name-style="western"><surname>Scior</surname><given-names>T</given-names></name><name name-style="western"><surname>Ammon</surname><given-names>HP</given-names></name></person-group><article-title>Binding of boswellic acids to functional proteins of the SARS-CoV-2 virus: bioinformatic studies</article-title><source>Arch Pharm</source><year>2021</year><volume>354</volume><issue>11</issue><fpage>2100160</fpage><pub-id pub-id-type="doi">10.1002/ardp.202100160</pub-id><pub-id pub-id-type="pmcid">PMC8646807</pub-id><pub-id pub-id-type="pmid">34427335</pub-id></element-citation></ref><ref id="CR16"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caligiuri</surname><given-names>P</given-names></name><name name-style="western"><surname>Cerruti</surname><given-names>R</given-names></name><name name-style="western"><surname>Icardi</surname><given-names>G</given-names></name><name name-style="western"><surname>Bruzzone</surname><given-names>B</given-names></name></person-group><article-title>Overview of hepatitis B virus mutations and their implications in the management of infection</article-title><source>World J Gastroenterol</source><year>2016</year><volume>22</volume><issue>1</issue><fpage>145</fpage><pub-id pub-id-type="doi">10.3748/wjg.v22.i1.145</pub-id><pub-id pub-id-type="pmid">26755866</pub-id><pub-id pub-id-type="pmcid">PMC4698481</pub-id></element-citation></ref><ref id="CR17"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>S-Y</given-names></name><name name-style="western"><surname>Huang</surname><given-names>K-Y</given-names></name><name name-style="western"><surname>Chao</surname><given-names>T-L</given-names></name><name name-style="western"><surname>Kao</surname><given-names>H-C</given-names></name><name name-style="western"><surname>Pang</surname><given-names>Y-H</given-names></name><name name-style="western"><surname>Lu</surname><given-names>L</given-names></name><etal/></person-group><article-title>Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses</article-title><source>Sci Rep</source><year>2021</year><volume>11</volume><issue>1</issue><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">33888738</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-021-87254-3</pub-id><pub-id pub-id-type="pmcid">PMC8062499</pub-id></element-citation></ref><ref id="CR18"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chib</surname><given-names>R</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>M</given-names></name><name name-style="western"><surname>Rizvi</surname><given-names>M</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S</given-names></name><name name-style="western"><surname>Pandey</surname><given-names>A</given-names></name><name name-style="western"><surname>Bani</surname><given-names>S</given-names></name><etal/></person-group><article-title>Anti-inflammatory terpenoids from Boswellia ovalifoliolata</article-title><source>RSC Adv</source><year>2014</year><volume>4</volume><issue>17</issue><fpage>8632</fpage><lpage>8637</lpage><pub-id pub-id-type="doi">10.1039/c3ra46412a</pub-id></element-citation></ref><ref id="CR19"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corey</surname><given-names>L</given-names></name><name name-style="western"><surname>Spear</surname><given-names>PG</given-names></name></person-group><article-title>Infections with herpes simplex viruses</article-title><source>N Engl J Med</source><year>1986</year><volume>314</volume><issue>11</issue><fpage>686</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1056/NEJM198603133141105</pub-id><pub-id pub-id-type="pmid">3005858</pub-id></element-citation></ref><ref id="CR20"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cosar</surname><given-names>B</given-names></name><name name-style="western"><surname>Karagulleoglu</surname><given-names>ZY</given-names></name><name name-style="western"><surname>Unal</surname><given-names>S</given-names></name><name name-style="western"><surname>Ince</surname><given-names>AT</given-names></name><name name-style="western"><surname>Uncuoglu</surname><given-names>DB</given-names></name><name name-style="western"><surname>Tuncer</surname><given-names>G</given-names></name><etal/></person-group><article-title>SARS-CoV-2 mutations and their viral variants</article-title><source>Cytokine Growth Factor Rev</source><year>2021</year><volume>63</volume><fpage>10</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.cytogfr.2021.06.001</pub-id><pub-id pub-id-type="pmid">34580015</pub-id><pub-id pub-id-type="pmcid">PMC8252702</pub-id></element-citation></ref><ref id="CR21"><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Cottey</surname><given-names>R</given-names></name><name name-style="western"><surname>Rowe</surname><given-names>C</given-names></name><name name-style="western"><surname>Bender</surname><given-names>B</given-names></name></person-group><source>Influenza virus current protocols in immunology</source><year>2001</year><publisher-loc>Maryland</publisher-loc><publisher-name>John Wiley &amp; Sons, Inc</publisher-name><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/0471142735.im1911s42</pub-id><pub-id pub-id-type="pmid">18432752</pub-id></element-citation></ref><ref id="CR22"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cox</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Khan</surname><given-names>KA</given-names></name><name name-style="western"><surname>Munday</surname><given-names>DL</given-names></name><name name-style="western"><surname>Sujja-Areevath</surname><given-names>J</given-names></name></person-group><article-title>Development and evaluation of a multiple-unit oral sustained release dosage form for S (+)-ibuprofen: preparation and release kinetics</article-title><source>Int J Pharm</source><year>1999</year><volume>193</volume><issue>1</issue><fpage>73</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/S0378-5173(99)00320-8</pub-id><pub-id pub-id-type="pmid">10581424</pub-id></element-citation></ref><ref id="CR23"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>de la Vega</surname><given-names>BA</given-names></name><name name-style="western"><surname>Barbancho</surname><given-names>ML</given-names></name></person-group><article-title>Hepatitis v&#237;ricas</article-title><source>Pediatr&#237;aintegral</source><year>2020</year><volume>7</volume><fpage>15</fpage></element-citation></ref><ref id="CR24"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeCarlo</surname><given-names>A</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>S</given-names></name><name name-style="western"><surname>Poudel</surname><given-names>A</given-names></name><name name-style="western"><surname>Satyal</surname><given-names>P</given-names></name><name name-style="western"><surname>Bangerter</surname><given-names>L</given-names></name><name name-style="western"><surname>Setzer</surname><given-names>WN</given-names></name></person-group><article-title>Chemical variation in essential oils from the oleo-gum resin of Boswellia carteri: a Preliminary investigation</article-title><source>Chem Biodivers</source><year>2018</year><volume>15</volume><issue>6</issue><fpage>e1800047</fpage><pub-id pub-id-type="doi">10.1002/cbdv.201800047</pub-id><pub-id pub-id-type="pmid">29696822</pub-id></element-citation></ref><ref id="CR25"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dunmire</surname><given-names>SK</given-names></name><name name-style="western"><surname>Verghese</surname><given-names>PS</given-names></name><name name-style="western"><surname>Balfour</surname><given-names>HH</given-names><suffix>Jr</suffix></name></person-group><article-title>Primary epstein-barr virus infection</article-title><source>J Clin Virol</source><year>2018</year><volume>102</volume><fpage>84</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.jcv.2018.03.001</pub-id><pub-id pub-id-type="pmid">29525635</pub-id></element-citation></ref><ref id="CR26"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durmu&#351;</surname><given-names>S</given-names></name><name name-style="western"><surname>&#220;lgen</surname><given-names>K&#214;</given-names></name></person-group><article-title>Comparative interactomics for virus&#8211;human protein&#8211;protein interactions: DNA viruses versus RNA viruses</article-title><source>FEBS Open Bio</source><year>2017</year><volume>7</volume><issue>1</issue><fpage>96</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1002/2211-5463.12167</pub-id><pub-id pub-id-type="pmid">28097092</pub-id><pub-id pub-id-type="pmcid">PMC5221455</pub-id></element-citation></ref><ref id="CR27"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emikpe</surname><given-names>BO</given-names></name><name name-style="western"><surname>Oyebanji</surname><given-names>VO</given-names></name><name name-style="western"><surname>Odeniyi</surname><given-names>MA</given-names></name><name name-style="western"><surname>Salaam</surname><given-names>AM</given-names></name><name name-style="western"><surname>Oladele</surname><given-names>OA</given-names></name><name name-style="western"><surname>Jarikre</surname><given-names>TA</given-names></name><etal/></person-group><article-title>Ex-vivo evaluation of the mucoadhesive properties of Cedrela odorata and Khaya senegalensis gums with possible applications for veterinary vaccine delivery</article-title><source>Springerplus</source><year>2016</year><volume>5</volume><issue>1</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1186/s40064-016-2948-0</pub-id><pub-id pub-id-type="pmid">27547664</pub-id><pub-id pub-id-type="pmcid">PMC4977245</pub-id></element-citation></ref><ref id="CR28"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feng</surname><given-names>W-h</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>JI</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Sneller</surname><given-names>M</given-names></name><name name-style="western"><surname>Goldbach-Mansky</surname><given-names>R</given-names></name><etal/></person-group><article-title>Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas</article-title><source>J Natl Cancer Inst</source><year>2004</year><volume>96</volume><issue>22</issue><fpage>1691</fpage><lpage>1702</lpage><pub-id pub-id-type="doi">10.1093/jnci/djh313</pub-id><pub-id pub-id-type="pmid">15547182</pub-id></element-citation></ref><ref id="CR29"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ganar</surname><given-names>K</given-names></name><name name-style="western"><surname>Das</surname><given-names>M</given-names></name><name name-style="western"><surname>Sinha</surname><given-names>S</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name></person-group><article-title>Newcastle disease virus: current status and our understanding</article-title><source>Virus Res</source><year>2014</year><volume>184</volume><fpage>71</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2014.02.016</pub-id><pub-id pub-id-type="pmid">24589707</pub-id><pub-id pub-id-type="pmcid">PMC7127793</pub-id></element-citation></ref><ref id="CR30"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garbutt</surname><given-names>M</given-names></name><name name-style="western"><surname>Liebscher</surname><given-names>R</given-names></name><name name-style="western"><surname>Wahl-Jensen</surname><given-names>V</given-names></name><name name-style="western"><surname>Jones</surname><given-names>S</given-names></name><name name-style="western"><surname>M&#246;ller</surname><given-names>P</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>R</given-names></name><etal/></person-group><article-title>Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses</article-title><source>J Virol</source><year>2004</year><volume>78</volume><issue>10</issue><fpage>5458</fpage><lpage>5465</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.10.5458-5465.2004</pub-id><pub-id pub-id-type="pmid">15113924</pub-id><pub-id pub-id-type="pmcid">PMC400370</pub-id></element-citation></ref><ref id="CR31"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goswami</surname><given-names>D</given-names></name><name name-style="western"><surname>Mahapatra</surname><given-names>AD</given-names></name><name name-style="western"><surname>Banerjee</surname><given-names>S</given-names></name><name name-style="western"><surname>Kar</surname><given-names>A</given-names></name><name name-style="western"><surname>Ojha</surname><given-names>D</given-names></name><name name-style="western"><surname>Mukherjee</surname><given-names>PK</given-names></name><etal/></person-group><article-title>Boswellia serrata oleo-gum-resin and &#946;-boswellic acid inhibits HSV-1 infection in vitro through modulation of NF-&#1082;B and p38 MAP kinase signaling</article-title><source>Phytomedicine</source><year>2018</year><volume>51</volume><fpage>94</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2018.10.016</pub-id><pub-id pub-id-type="pmid">30466633</pub-id></element-citation></ref><ref id="CR32"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greve</surname><given-names>HL</given-names></name><name name-style="western"><surname>Kaiser</surname><given-names>M</given-names></name><name name-style="western"><surname>Brun</surname><given-names>R</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>TJ</given-names></name></person-group><article-title>Terpenoids from the oleo-gum-resin of Boswellia serrata and their antiplasmodial effects in vitro</article-title><source>Planta Med</source><year>2017</year><volume>83</volume><issue>14/15</issue><fpage>1214</fpage><lpage>1226</lpage><pub-id pub-id-type="doi">10.1055/s-0043-116943</pub-id><pub-id pub-id-type="pmid">28738439</pub-id></element-citation></ref><ref id="CR33"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>A</given-names></name><name name-style="western"><surname>Khajuria</surname><given-names>A</given-names></name><name name-style="western"><surname>Singh</surname><given-names>J</given-names></name><name name-style="western"><surname>Singh</surname><given-names>S</given-names></name><name name-style="western"><surname>Suri</surname><given-names>K</given-names></name><name name-style="western"><surname>Qazi</surname><given-names>G</given-names></name></person-group><article-title>Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice</article-title><source>Int Immunopharmacol</source><year>2011</year><volume>11</volume><issue>8</issue><fpage>968</fpage><lpage>975</lpage><pub-id pub-id-type="doi">10.1016/j.intimp.2011.02.011</pub-id><pub-id pub-id-type="pmid">21371582</pub-id></element-citation></ref><ref id="CR34"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hawkins</surname><given-names>J</given-names></name><name name-style="western"><surname>Hires</surname><given-names>C</given-names></name><name name-style="western"><surname>Keenan</surname><given-names>L</given-names></name><name name-style="western"><surname>Dunne</surname><given-names>E</given-names></name></person-group><article-title>Aromatherapy blend of thyme, orange, clove bud, and frankincense boosts energy levels in post-COVID-19 female patients: A randomized, double-blinded, placebo controlled clinical trial</article-title><source>Complement Ther Med</source><year>2022</year><volume>67</volume><fpage>102823</fpage><pub-id pub-id-type="doi">10.1016/j.ctim.2022.102823</pub-id><pub-id pub-id-type="pmid">35341944</pub-id><pub-id pub-id-type="pmcid">PMC8949693</pub-id></element-citation></ref><ref id="CR35"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heiat</surname><given-names>M</given-names></name><name name-style="western"><surname>Hashemi-Aghdam</surname><given-names>M-R</given-names></name><name name-style="western"><surname>Heiat</surname><given-names>F</given-names></name><name name-style="western"><surname>Rastegar Shariat Panahi</surname><given-names>M</given-names></name><name name-style="western"><surname>Aghamollaei</surname><given-names>H</given-names></name><name name-style="western"><surname>Moosazadeh Moghaddam</surname><given-names>M</given-names></name><etal/></person-group><article-title>Integrative role of traditional and modern technologies to combat COVID-19</article-title><source>Expert Rev Anti Infect Ther</source><year>2021</year><volume>19</volume><issue>1</issue><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1080/14787210.2020.1799784</pub-id><pub-id pub-id-type="pmid">32703036</pub-id></element-citation></ref><ref id="CR36"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>B</given-names></name><name name-style="western"><surname>Huang</surname><given-names>S</given-names></name><name name-style="western"><surname>Yin</surname><given-names>L</given-names></name></person-group><article-title>The cytokine storm and COVID-19</article-title><source>J Med Virol</source><year>2021</year><volume>93</volume><issue>1</issue><fpage>250</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1002/jmv.26232</pub-id><pub-id pub-id-type="pmid">32592501</pub-id><pub-id pub-id-type="pmcid">PMC7361342</pub-id></element-citation></ref><ref id="CR37"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>AL</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>MAK</given-names></name></person-group><article-title>More effective purifying selection on RNA viruses than in DNA viruses</article-title><source>Gene</source><year>2007</year><volume>404</volume><issue>1&#8211;2</issue><fpage>117</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1016/j.gene.2007.09.013</pub-id><pub-id pub-id-type="pmid">17928171</pub-id><pub-id pub-id-type="pmcid">PMC2756238</pub-id></element-citation></ref><ref id="CR38"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hussein</surname><given-names>G</given-names></name><name name-style="western"><surname>Miyashiro</surname><given-names>H</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>N</given-names></name><name name-style="western"><surname>Hattori</surname><given-names>M</given-names></name><name name-style="western"><surname>Kakiuchi</surname><given-names>N</given-names></name><name name-style="western"><surname>Shimotohno</surname><given-names>K</given-names></name></person-group><article-title>Inhibitory effects of Sudanese medicinal plant extracts on hepatitis C virus (HCV) protease</article-title><source>Phytother Res Int J Devot Pharmacol Toxicol Eval Nat Prod Deriv</source><year>2000</year><volume>14</volume><issue>7</issue><fpage>510</fpage><lpage>516</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1099-1573(200011)14:7&lt;510::aid-ptr646&gt;3.0.co;2-b</pub-id><pub-id pub-id-type="pmid">11054840</pub-id></element-citation></ref><ref id="CR5"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ignjatovi&#263;</surname><given-names>J</given-names></name><name name-style="western"><surname>Sapats</surname><given-names>S</given-names></name></person-group><article-title>Avian infectious bronchitis virus</article-title><source>Revue scientifique et technique (International Office of Epizootics)</source><year>2000</year><volume>19</volume><issue>2</issue><fpage>493</fpage><lpage>508</lpage><pub-id pub-id-type="pmid">10935276</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.20506/rst.19.2.1228</pub-id></element-citation></ref><ref id="CR39"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ismail</surname><given-names>SM</given-names></name><name name-style="western"><surname>Aluru</surname><given-names>S</given-names></name><name name-style="western"><surname>Sambasivarao</surname><given-names>K</given-names></name><name name-style="western"><surname>Matcha</surname><given-names>B</given-names></name></person-group><article-title>Antimicrobial activity of frankincense of Boswellia serrata</article-title><source>Int J Curr Microbiol App Sci</source><year>2014</year><volume>3</volume><issue>10</issue><fpage>1095</fpage><lpage>1101</lpage></element-citation></ref><ref id="CR40"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jansi</surname><given-names>RS</given-names></name><name name-style="western"><surname>Khusro</surname><given-names>A</given-names></name><name name-style="western"><surname>Agastian</surname><given-names>P</given-names></name><name name-style="western"><surname>Alfarhan</surname><given-names>A</given-names></name><name name-style="western"><surname>Al-Dhabi</surname><given-names>NA</given-names></name><name name-style="western"><surname>Arasu</surname><given-names>MV</given-names></name><etal/></person-group><article-title>Emerging paradigms of viral diseases and paramount role of natural resources as antiviral agents</article-title><source>Sci Total Environ</source><year>2021</year><volume>759</volume><fpage>143539</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.143539</pub-id><pub-id pub-id-type="pmid">33234268</pub-id><pub-id pub-id-type="pmcid">PMC7833357</pub-id></element-citation></ref><ref id="CR41"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jassim</surname><given-names>SA</given-names></name><name name-style="western"><surname>Naji</surname><given-names>MA</given-names></name></person-group><article-title>Novel antiviral agents: a medicinal plant perspective</article-title><source>J Appl Microbiol</source><year>2003</year><volume>95</volume><issue>3</issue><fpage>412</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2672.2003.02026.x</pub-id><pub-id pub-id-type="pmid">12911688</pub-id></element-citation></ref><ref id="CR42"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>S</given-names></name><name name-style="western"><surname>DeCarlo</surname><given-names>A</given-names></name><name name-style="western"><surname>Satyal</surname><given-names>P</given-names></name><name name-style="western"><surname>Dosoky</surname><given-names>NS</given-names></name><name name-style="western"><surname>Sorensen</surname><given-names>A</given-names></name><name name-style="western"><surname>Setzer</surname><given-names>WN</given-names></name></person-group><article-title>The chemical composition of single-tree Boswellia frereana resin samples</article-title><source>Nat Prod Commun</source><year>2021</year><volume>16</volume><issue>9</issue><fpage>1934578X211043727</fpage></element-citation></ref><ref id="CR43"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kadam</surname><given-names>U</given-names></name><name name-style="western"><surname>Khalkar</surname><given-names>K</given-names></name><name name-style="western"><surname>Kadam</surname><given-names>V</given-names></name></person-group><article-title>Biochemical profile of Boswellia serrata and Rhus mysorensis</article-title><source>J Drug Deliv Ther</source><year>2021</year><volume>11</volume><issue>4&#8211;S</issue><fpage>131</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.22270/jddt.v11i4-S.4975</pub-id></element-citation></ref><ref id="CR44"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kadhim</surname><given-names>MM</given-names></name><name name-style="western"><surname>Salman</surname><given-names>AW</given-names></name><name name-style="western"><surname>Zarzoor</surname><given-names>AM</given-names></name><name name-style="western"><surname>Kadhum</surname><given-names>WR</given-names></name></person-group><article-title>Inhibition of SARS-CoV-2 reproduction using Boswellia carterii: a theoretical study</article-title><source>J Mol Liq</source><year>2021</year><volume>337</volume><fpage>116440</fpage><pub-id pub-id-type="doi">10.1016/j.molliq.2021.116440</pub-id><pub-id pub-id-type="pmid">33994607</pub-id><pub-id pub-id-type="pmcid">PMC8105125</pub-id></element-citation></ref><ref id="CR45"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karimifar</surname><given-names>M</given-names></name><name name-style="western"><surname>Soltani</surname><given-names>R</given-names></name><name name-style="western"><surname>Hajhashemi</surname><given-names>V</given-names></name><name name-style="western"><surname>Sarrafchi</surname><given-names>S</given-names></name></person-group><article-title>Evaluation of the effect of Elaeagnus angustifolia alone and combined with Boswellia thurifera compared with ibuprofen in patients with knee osteoarthritis: a randomized double-blind controlled clinical trial</article-title><source>Clin Rheumatol</source><year>2017</year><volume>36</volume><issue>8</issue><fpage>1849</fpage><lpage>1853</lpage><pub-id pub-id-type="doi">10.1007/s10067-017-3603-z</pub-id><pub-id pub-id-type="pmid">28349271</pub-id></element-citation></ref><ref id="CR46"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keri Lestari</surname><given-names>HB</given-names></name><name name-style="western"><surname>Babikyan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Megantara</surname><given-names>I</given-names></name><name name-style="western"><surname>Jha</surname><given-names>RK</given-names></name><name name-style="western"><surname>Kusuma</surname><given-names>ASW</given-names></name><name name-style="western"><surname>Novantiana</surname><given-names>MP</given-names></name><name name-style="western"><surname>Sudirman</surname><given-names>FX</given-names></name></person-group><article-title>Deactivation of Avian infectious bronchitis virus H120 using natural oil blend on in vitro medium</article-title><source>Asian J Poult Sci</source><year>2021</year><volume>15</volume><fpage>24</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.3923/ajpsaj.2021.24.30</pub-id></element-citation></ref><ref id="CR47"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kimmatkar</surname><given-names>N</given-names></name><name name-style="western"><surname>Thawani</surname><given-names>V</given-names></name><name name-style="western"><surname>Hingorani</surname><given-names>L</given-names></name><name name-style="western"><surname>Khiyani</surname><given-names>R</given-names></name></person-group><article-title>Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee&#8211;a randomized double blind placebo controlled trial</article-title><source>Phytomedicine</source><year>2003</year><volume>10</volume><issue>1</issue><fpage>3</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1078/094471103321648593</pub-id><pub-id pub-id-type="pmid">12622457</pub-id></element-citation></ref><ref id="CR48"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knaus</surname><given-names>U</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>H</given-names></name></person-group><article-title>Effects of boswellic acid of Boswellia serrata and other triterpenic acids on the complement system</article-title><source>Phytomedicine</source><year>1996</year><volume>3</volume><issue>1</issue><fpage>77</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/S0944-7113(96)80016-X</pub-id><pub-id pub-id-type="pmid">23194867</pub-id></element-citation></ref><ref id="CR49"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kohoude</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Gbaguidi</surname><given-names>F</given-names></name><name name-style="western"><surname>Agbani</surname><given-names>P</given-names></name><name name-style="western"><surname>Ayedoun</surname><given-names>M-A</given-names></name><name name-style="western"><surname>Cazaux</surname><given-names>S</given-names></name><name name-style="western"><surname>Bouajila</surname><given-names>J</given-names></name></person-group><article-title>Chemical composition and biological activities of extracts and essential oil of Boswellia dalzielii leaves</article-title><source>Pharm Biol</source><year>2017</year><volume>55</volume><issue>1</issue><fpage>33</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1080/13880209.2016.1226356</pub-id><pub-id pub-id-type="pmid">27650786</pub-id><pub-id pub-id-type="pmcid">PMC7011857</pub-id></element-citation></ref><ref id="CR50"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kulkarni</surname><given-names>R</given-names></name><name name-style="western"><surname>Patki</surname><given-names>P</given-names></name><name name-style="western"><surname>Jog</surname><given-names>V</given-names></name><name name-style="western"><surname>Gandage</surname><given-names>S</given-names></name><name name-style="western"><surname>Patwardhan</surname><given-names>B</given-names></name></person-group><article-title>Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study</article-title><source>J Ethnopharmacol</source><year>1991</year><volume>33</volume><issue>1&#8211;2</issue><fpage>91</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1016/0378-8741(91)90167-C</pub-id><pub-id pub-id-type="pmid">1943180</pub-id></element-citation></ref><ref id="CR51"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>N</given-names></name><name name-style="western"><surname>Maherchandani</surname><given-names>S</given-names></name><name name-style="western"><surname>Kashyap</surname><given-names>SK</given-names></name><name name-style="western"><surname>Singh</surname><given-names>SV</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>S</given-names></name><name name-style="western"><surname>Chaubey</surname><given-names>KK</given-names></name><etal/></person-group><article-title>Peste des petits ruminants virus infection of small ruminants: a comprehensive review</article-title><source>Viruses</source><year>2014</year><volume>6</volume><issue>6</issue><fpage>2287</fpage><lpage>2327</lpage><pub-id pub-id-type="doi">10.3390/v6062287</pub-id><pub-id pub-id-type="pmid">24915458</pub-id><pub-id pub-id-type="pmcid">PMC4074929</pub-id></element-citation></ref><ref id="CR52"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kwiatek</surname><given-names>O</given-names></name><name name-style="western"><surname>Minet</surname><given-names>C</given-names></name><name name-style="western"><surname>Grillet</surname><given-names>C</given-names></name><name name-style="western"><surname>Hurard</surname><given-names>C</given-names></name><name name-style="western"><surname>Carlsson</surname><given-names>E</given-names></name><name name-style="western"><surname>Karimov</surname><given-names>B</given-names></name><etal/></person-group><article-title>Peste des petits ruminants (PPR) outbreak in Tajikistan</article-title><source>J Comp Pathol</source><year>2007</year><volume>136</volume><issue>2&#8211;3</issue><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.jcpa.2006.12.002</pub-id><pub-id pub-id-type="pmid">17321539</pub-id></element-citation></ref><ref id="CR53"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Majeed</surname><given-names>M</given-names></name><name name-style="western"><surname>Majeed</surname><given-names>S</given-names></name><name name-style="western"><surname>Narayanan</surname><given-names>NK</given-names></name><name name-style="western"><surname>Nagabhushanam</surname><given-names>K</given-names></name></person-group><article-title>A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee</article-title><source>Phytother Res</source><year>2019</year><volume>33</volume><issue>5</issue><fpage>1457</fpage><lpage>1468</lpage><pub-id pub-id-type="doi">10.1002/ptr.6338</pub-id><pub-id pub-id-type="pmid">30838706</pub-id><pub-id pub-id-type="pmcid">PMC6681146</pub-id></element-citation></ref><ref id="CR54"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manjula</surname><given-names>B</given-names></name><name name-style="western"><surname>Srinatha</surname><given-names>A</given-names></name><name name-style="western"><surname>Sridhar</surname><given-names>B</given-names></name></person-group><article-title>Evaluation of hydrophilic polymers and their combinations in formulation of sustained-release matrix tablets of water-soluble drug</article-title><source>Ind J Pharmaceut Educ Res</source><year>2014</year><volume>48</volume><fpage>48</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.5530/ijper.48.3.7</pub-id></element-citation></ref><ref id="CR55"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marefati</surname><given-names>N</given-names></name><name name-style="western"><surname>Beheshti</surname><given-names>F</given-names></name><name name-style="western"><surname>Etemadizadeh</surname><given-names>P</given-names></name><name name-style="western"><surname>Hosseini</surname><given-names>M</given-names></name><name name-style="western"><surname>Anaeigoudari</surname><given-names>A</given-names></name></person-group><article-title>Gum resin extract of Boswellia serrata attenuates lipopolysaccharide-induced inflammation and oxidative damage in hepatic and renal tissues of rats</article-title><source>Asian Pac J Trop Biomed</source><year>2022</year><volume>12</volume><issue>1</issue><fpage>20</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.4103/2221-1691.333210</pub-id></element-citation></ref><ref id="CR56"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meganck</surname><given-names>RM</given-names></name><name name-style="western"><surname>Baric</surname><given-names>RS</given-names></name></person-group><article-title>Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases</article-title><source>Nat Med</source><year>2021</year><volume>27</volume><issue>3</issue><fpage>401</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01282-0</pub-id><pub-id pub-id-type="pmid">33723456</pub-id></element-citation></ref><ref id="CR57"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mothana</surname><given-names>RA</given-names></name><name name-style="western"><surname>Mentel</surname><given-names>R</given-names></name><name name-style="western"><surname>Reiss</surname><given-names>C</given-names></name><name name-style="western"><surname>Lindequist</surname><given-names>U</given-names></name></person-group><article-title>Phytochemical screening and antiviral activity of some medicinal plants from the island Soqotra</article-title><source>Phytother Res an Int J Devot Pharmacol Toxicol Eval Nat Prod Deriv</source><year>2006</year><volume>20</volume><issue>4</issue><fpage>298</fpage><lpage>302</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ptr.1858</pub-id><pub-id pub-id-type="pmid">16557613</pub-id></element-citation></ref><ref id="CR58"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mumin</surname><given-names>FI</given-names></name><name name-style="western"><surname>Emikpe</surname><given-names>BO</given-names></name><name name-style="western"><surname>Odeniyi</surname><given-names>MA</given-names></name></person-group><article-title>Evaluation of mucoadhesive property and the effect of Boswellia carteri gum on intranasal vaccination against small ruminant morbillivirus infection (PPR)</article-title><source>J Immunoassay Immunochem</source><year>2020</year><volume>41</volume><issue>3</issue><fpage>311</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1080/15321819.2020.1734935</pub-id><pub-id pub-id-type="pmid">32119592</pub-id></element-citation></ref><ref id="CR59"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Munir</surname><given-names>M</given-names></name><name name-style="western"><surname>Zohari</surname><given-names>S</given-names></name><name name-style="western"><surname>Abbas</surname><given-names>M</given-names></name><name name-style="western"><surname>Berg</surname><given-names>M</given-names></name></person-group><article-title>Sequencing and analysis of the complete genome of Newcastle disease virus isolated from a commercial poultry farm in 2010</article-title><source>Adv Virol</source><year>2012</year><volume>157</volume><issue>4</issue><fpage>765</fpage><lpage>768</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00705-011-1220-8</pub-id><pub-id pub-id-type="pmid">22218968</pub-id></element-citation></ref><ref id="CR60"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohemu</surname><given-names>T</given-names></name><name name-style="western"><surname>Agunu</surname><given-names>A</given-names></name><name name-style="western"><surname>Chollom</surname><given-names>S</given-names></name><name name-style="western"><surname>Okwori</surname><given-names>V</given-names></name><name name-style="western"><surname>Dalen</surname><given-names>D</given-names></name><name name-style="western"><surname>Olotu</surname><given-names>P</given-names></name></person-group><article-title>Preliminary phytochemical screening and antiviral potential of methanol stem bark extract of Enantia chlorantha Oliver (Annonaceae) and Boswellia dalzielii Hutch (Burseraceae) against Newcastle disease in Ovo</article-title><source>EJMP</source><year>2018</year><volume>25</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.9734/EJMP/2018/44919</pub-id></element-citation></ref><ref id="CR61"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ohemu</surname><given-names>TL</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>A</given-names></name><name name-style="western"><surname>Alemika</surname><given-names>TE</given-names></name><name name-style="western"><surname>Chollom</surname><given-names>SC</given-names></name><name name-style="western"><surname>Yakubu</surname><given-names>TP</given-names></name><name name-style="western"><surname>Dafam</surname><given-names>DG</given-names></name><etal/></person-group><article-title>In-ovo biological activity of Boswellia dalzielii stem bark extract and fractions against Newcastle disease virus</article-title><source>J Pharmacogn Phytother</source><year>2020</year><volume>12</volume><issue>3</issue><fpage>62</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.5897/JPP2019.0556</pub-id></element-citation></ref><ref id="CR62"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ola</surname><given-names>O</given-names></name><name name-style="western"><surname>Jarikre</surname><given-names>TA</given-names></name><name name-style="western"><surname>Adeniran</surname><given-names>G</given-names></name><name name-style="western"><surname>Odeniyi</surname><given-names>M</given-names></name><name name-style="western"><surname>Emikpe</surname><given-names>B</given-names></name></person-group><article-title>Evaluation of oral phytogenic microbeaded Newcastle disease vaccine delivery in indigenous chicken</article-title><source>J Immunoassay Immunochem</source><year>2021</year><volume>42</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1080/15321819.2020.1868001</pub-id><pub-id pub-id-type="pmid">33560901</pub-id></element-citation></ref><ref id="CR63"><mixed-citation publication-type="other">Organization WH (2020) Coronavirus disease (COVID-19): situation report. 171</mixed-citation></ref><ref id="CR64"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pal</surname><given-names>M</given-names></name><name name-style="western"><surname>Berhanu</surname><given-names>G</given-names></name><name name-style="western"><surname>Desalegn</surname><given-names>C</given-names></name><name name-style="western"><surname>Kandi</surname><given-names>V</given-names></name></person-group><article-title>Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an update</article-title><source>Cureus</source><year>2020</year><pub-id pub-id-type="doi">10.7759/cureus.7423</pub-id><pub-id pub-id-type="pmid">32337143</pub-id><pub-id pub-id-type="pmcid">PMC7182166</pub-id></element-citation></ref><ref id="CR65"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>Y-N</given-names></name><name name-style="western"><surname>Liang</surname><given-names>X-X</given-names></name><name name-style="western"><surname>Niu</surname><given-names>L-Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y-N</given-names></name><name name-style="western"><surname>Tong</surname><given-names>X</given-names></name><name name-style="western"><surname>Hua</surname><given-names>H-M</given-names></name><etal/></person-group><article-title>Comparative studies of pharmacokinetics and anticoagulatory effect in rats after oral administration of Frankincense and its processed products</article-title><source>J Ethnopharmacol</source><year>2015</year><volume>172</volume><fpage>118</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2015.06.029</pub-id><pub-id pub-id-type="pmid">26117531</pub-id></element-citation></ref><ref id="CR66"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pasternak</surname><given-names>B</given-names></name><name name-style="western"><surname>Hviid</surname><given-names>A</given-names></name></person-group><article-title>Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects</article-title><source>JAMA</source><year>2010</year><volume>304</volume><issue>8</issue><fpage>859</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1001/jama.2010.1206</pub-id><pub-id pub-id-type="pmid">20736469</pub-id></element-citation></ref><ref id="CR67"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peppas</surname><given-names>NA</given-names></name><name name-style="western"><surname>Sahlin</surname><given-names>JJ</given-names></name></person-group><article-title>Hydrogels as mucoadhesive and bioadhesive materials: a review</article-title><source>Biomaterials</source><year>1996</year><volume>17</volume><issue>16</issue><fpage>1553</fpage><lpage>1561</lpage><pub-id pub-id-type="doi">10.1016/0142-9612(95)00307-X</pub-id><pub-id pub-id-type="pmid">8842358</pub-id></element-citation></ref><ref id="CR68"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pilkhwal</surname><given-names>N</given-names></name><name name-style="western"><surname>Dhaneshwar</surname><given-names>S</given-names></name></person-group><article-title>An update on pharmacological profile of Boswellia serrata</article-title><source>Asian J Pharm Clin Res</source><year>2019</year><volume>12</volume><issue>5</issue><fpage>49</fpage><lpage>56</lpage></element-citation></ref><ref id="CR69"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prakash</surname><given-names>B</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>PK</given-names></name><name name-style="western"><surname>Kedia</surname><given-names>A</given-names></name><name name-style="western"><surname>Dubey</surname><given-names>N</given-names></name></person-group><article-title>Antifungal, antiaflatoxin and antioxidant potential of chemically characterized Boswellia carterii Birdw essential oil and its in vivo practical applicability in preservation of Piper nigrum L. fruits</article-title><source>LWT Food Sci Technol</source><year>2014</year><volume>56</volume><issue>2</issue><fpage>240</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.lwt.2013.12.023</pub-id></element-citation></ref><ref id="CR70"><element-citation publication-type="book"><person-group person-group-type="editor"><name name-style="western"><surname>Pullen</surname><given-names>MF</given-names></name><name name-style="western"><surname>Skipper</surname><given-names>CP</given-names></name><name name-style="western"><surname>Hullsiek</surname><given-names>KH</given-names></name><name name-style="western"><surname>Bangdiwala</surname><given-names>AS</given-names></name><name name-style="western"><surname>Pastick</surname><given-names>KA</given-names></name><name name-style="western"><surname>Okafor</surname><given-names>EC</given-names></name><etal/></person-group><source>Symptoms of COVID-19 outpatients in the United States. Open forum infectious diseases</source><year>2020</year><publisher-loc>US</publisher-loc><publisher-name>Oxford University Press</publisher-name><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ofid/ofaa271</pub-id><pub-id pub-id-type="pmcid">PMC7337847</pub-id><pub-id pub-id-type="pmid">33117855</pub-id></element-citation></ref><ref id="CR71"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rashan</surname><given-names>L</given-names></name><name name-style="western"><surname>Hakkim</surname><given-names>FL</given-names></name><name name-style="western"><surname>Idrees</surname><given-names>M</given-names></name><name name-style="western"><surname>Essa</surname><given-names>MM</given-names></name><name name-style="western"><surname>Velusamy</surname><given-names>T</given-names></name><name name-style="western"><surname>Al-Baloshi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Boswellia gum resin and essential oils: potential health benefits&#8722;an evidence based review</article-title><source>Int J Nutr Pharmacol Neurol Dis</source><year>2019</year><volume>9</volume><issue>2</issue><fpage>53</fpage><pub-id pub-id-type="doi">10.4103/ijnpnd.ijnpnd_11_19</pub-id></element-citation></ref><ref id="CR72"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rothan</surname><given-names>HA</given-names></name><name name-style="western"><surname>Byrareddy</surname><given-names>SN</given-names></name></person-group><article-title>The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak</article-title><source>J Autoimmun</source><year>2020</year><volume>109</volume><fpage>102433</fpage><pub-id pub-id-type="doi">10.1016/j.jaut.2020.102433</pub-id><pub-id pub-id-type="pmid">32113704</pub-id><pub-id pub-id-type="pmcid">PMC7127067</pub-id></element-citation></ref><ref id="CR73"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roy</surname><given-names>A</given-names></name><name name-style="western"><surname>Menon</surname><given-names>T</given-names></name></person-group><article-title>Evaluation of bioactive compounds from Boswellia serrata against SARS-CoV-2</article-title><source>Vegetos</source><year>2021</year><volume>35</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s42535-021-00318-7</pub-id><pub-id pub-id-type="pmcid">PMC8595075</pub-id><pub-id pub-id-type="pmid">34803247</pub-id></element-citation></ref><ref id="CR74"><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Satpathy</surname><given-names>R</given-names></name></person-group><source>Therapeutic importance and application of boswellic acid from the plant Boswellia serrate. Advanced pharmacological uses of medicinal plants and natural products</source><year>2020</year><publisher-loc>Pennsylvania</publisher-loc><publisher-name>IGI Global</publisher-name><fpage>302</fpage><lpage>315</lpage></element-citation></ref><ref id="CR75"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schaefer</surname><given-names>M</given-names></name><name name-style="western"><surname>Hinzpeter</surname><given-names>A</given-names></name><name name-style="western"><surname>Mohmand</surname><given-names>A</given-names></name><name name-style="western"><surname>Janssen</surname><given-names>G</given-names></name><name name-style="western"><surname>Pich</surname><given-names>M</given-names></name><name name-style="western"><surname>Schwaiger</surname><given-names>M</given-names></name><etal/></person-group><article-title>Hepatitis C treatment in &#8220;difficult-to-treat&#8221; psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects</article-title><source>Hepatology</source><year>2007</year><volume>46</volume><issue>4</issue><fpage>991</fpage><lpage>998</lpage><pub-id pub-id-type="doi">10.1002/hep.21791</pub-id><pub-id pub-id-type="pmid">17668880</pub-id></element-citation></ref><ref id="CR76"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sengupta</surname><given-names>K</given-names></name><name name-style="western"><surname>Krishnaraju</surname><given-names>AV</given-names></name><name name-style="western"><surname>Vishal</surname><given-names>AA</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>A</given-names></name><name name-style="western"><surname>Trimurtulu</surname><given-names>G</given-names></name><name name-style="western"><surname>Sarma</surname><given-names>KV</given-names></name><etal/></person-group><article-title>Comparative efficacy and tolerability of 5-Loxin&#174; and Aflapin&#174; against osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study</article-title><source>Int J Med Sci</source><year>2010</year><volume>7</volume><issue>6</issue><fpage>366</fpage><pub-id pub-id-type="doi">10.7150/ijms.7.366</pub-id><pub-id pub-id-type="pmid">21060724</pub-id><pub-id pub-id-type="pmcid">PMC2974165</pub-id></element-citation></ref><ref id="CR77"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>A</given-names></name><name name-style="western"><surname>Mann</surname><given-names>A</given-names></name><name name-style="western"><surname>Gajbhiye</surname><given-names>V</given-names></name><name name-style="western"><surname>Kharya</surname><given-names>M</given-names></name></person-group><article-title>PHCOG REV.: plant review phytochemical profile of Boswellia serrata: an overview</article-title><source>Pharmacogn Rev</source><year>2007</year><volume>1</volume><issue>1</issue><fpage>131</fpage><lpage>142</lpage></element-citation></ref><ref id="CR78"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>R</given-names></name><name name-style="western"><surname>Singh</surname><given-names>S</given-names></name><name name-style="western"><surname>Singh</surname><given-names>G</given-names></name><name name-style="western"><surname>Khajuria</surname><given-names>A</given-names></name><name name-style="western"><surname>Sidiq</surname><given-names>T</given-names></name><name name-style="western"><surname>Singh</surname><given-names>S</given-names></name><etal/></person-group><article-title>In vivo genotoxicity evaluation of a plant based antiarthritic and anticancer therapeutic agent Boswelic acids in rodents</article-title><source>Phytomedicine</source><year>2009</year><volume>16</volume><issue>12</issue><fpage>1112</fpage><lpage>1118</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2009.06.009</pub-id><pub-id pub-id-type="pmid">19679457</pub-id></element-citation></ref><ref id="CR87"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>A</given-names></name><name name-style="western"><surname>Shalini</surname><given-names>T</given-names></name><name name-style="western"><surname>Sriranjini</surname><given-names>S</given-names></name><name name-style="western"><surname>Venkatesh</surname><given-names>B</given-names></name></person-group><article-title>Management strategies for Janu Sandhigata Vata vis-a-vis osteoartheritis of knee: a narrative review</article-title><source>Ayu</source><year>2016</year><volume>37</volume><issue>1</issue><fpage>11</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.4103/ayu.AYU_24_16</pub-id><pub-id pub-id-type="pmid">28827949</pub-id><pub-id pub-id-type="pmcid">PMC5541460</pub-id></element-citation></ref><ref id="CR79"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siddiqui</surname><given-names>M</given-names></name></person-group><article-title>Boswellia serrata, a potential antiinflammatory agent: an overview</article-title><source>Indian J Pharm Sci</source><year>2011</year><volume>73</volume><issue>3</issue><fpage>255</fpage><pub-id pub-id-type="pmid">22457547</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/0250-474X.93507</pub-id><pub-id pub-id-type="pmcid">PMC3309643</pub-id></element-citation></ref><ref id="CR80"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simon</surname><given-names>F</given-names></name><name name-style="western"><surname>Javelle</surname><given-names>E</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>M</given-names></name><name name-style="western"><surname>Leparc-Goffart</surname><given-names>I</given-names></name><name name-style="western"><surname>Marimoutou</surname><given-names>C</given-names></name></person-group><article-title>Chikungunya virus infection</article-title><source>Curr Infect Dis Rep</source><year>2011</year><volume>13</volume><issue>3</issue><fpage>218</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1007/s11908-011-0180-1</pub-id><pub-id pub-id-type="pmid">21465340</pub-id><pub-id pub-id-type="pmcid">PMC3085104</pub-id></element-citation></ref><ref id="CR81"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>P</given-names></name><name name-style="western"><surname>Chacko</surname><given-names>KM</given-names></name><name name-style="western"><surname>Aggarwal</surname><given-names>M</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>B</given-names></name><name name-style="western"><surname>Khandal</surname><given-names>R</given-names></name><name name-style="western"><surname>Sultana</surname><given-names>S</given-names></name><etal/></person-group><article-title>A-90 day gavage safety assessment of Boswellia serrata in rats</article-title><source>Toxicol Int</source><year>2012</year><volume>19</volume><issue>3</issue><fpage>273</fpage><pub-id pub-id-type="doi">10.4103/0971-6580.103668</pub-id><pub-id pub-id-type="pmid">23293466</pub-id><pub-id pub-id-type="pmcid">PMC3532773</pub-id></element-citation></ref><ref id="CR82"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sinkovics</surname><given-names>JG</given-names></name><name name-style="western"><surname>Horvath</surname><given-names>JC</given-names></name></person-group><article-title>Newcastle disease virus (NDV): brief history of its oncolytic strains</article-title><source>J Clin Virol</source><year>2000</year><volume>16</volume><issue>1</issue><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/S1386-6532(99)00072-4</pub-id><pub-id pub-id-type="pmid">10680736</pub-id></element-citation></ref><ref id="CR83"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smart</surname><given-names>J</given-names></name><name name-style="western"><surname>Kellaway</surname><given-names>I</given-names></name><name name-style="western"><surname>Worthington</surname><given-names>H</given-names></name></person-group><article-title>An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery</article-title><source>J Pharm Pharmacol</source><year>1984</year><volume>36</volume><issue>5</issue><fpage>295</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1111/j.2042-7158.1984.tb04377.x</pub-id><pub-id pub-id-type="pmid">6145763</pub-id></element-citation></ref><ref id="CR84"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sultana</surname><given-names>A</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>KU</given-names></name><name name-style="western"><surname>Padmaja</surname><given-names>A</given-names></name><name name-style="western"><surname>Rahman</surname><given-names>SU</given-names></name></person-group><article-title>Boswellia serrata Roxb. a traditional herb with versatile pharmacological activity: a review</article-title><source>Int J Pharm Sci Res</source><year>2013</year><volume>4</volume><issue>6</issue><fpage>2106</fpage></element-citation></ref><ref id="CR85"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ul Qamar</surname><given-names>MT</given-names></name><name name-style="western"><surname>Alqahtani</surname><given-names>SM</given-names></name><name name-style="western"><surname>Alamri</surname><given-names>MA</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L-L</given-names></name></person-group><article-title>Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants</article-title><source>J Pharm Anal</source><year>2020</year><volume>10</volume><issue>4</issue><fpage>313</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1016/j.jpha.2020.03.009</pub-id><pub-id pub-id-type="pmid">32296570</pub-id><pub-id pub-id-type="pmcid">PMC7156227</pub-id></element-citation></ref><ref id="CR86"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Upaganlawar</surname><given-names>A</given-names></name><name name-style="western"><surname>Ghule</surname><given-names>B</given-names></name></person-group><article-title>Pharmacological activities of Boswellia serrata Roxb.-mini review</article-title><source>Ethnobot Leafl</source><year>2009</year><volume>2009</volume><issue>6</issue><fpage>10</fpage></element-citation></ref><ref id="CR88"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Rhein</surname><given-names>C</given-names></name><name name-style="western"><surname>Weidner</surname><given-names>T</given-names></name><name name-style="western"><surname>Hen&#223;</surname><given-names>L</given-names></name><name name-style="western"><surname>Martin</surname><given-names>J</given-names></name><name name-style="western"><surname>Weber</surname><given-names>C</given-names></name><name name-style="western"><surname>Sliva</surname><given-names>K</given-names></name><etal/></person-group><article-title>Curcumin and Boswellia serrata gum resin extract inhibit chikungunya and vesicular stomatitis virus infections in vitro</article-title><source>Antiviral Res</source><year>2016</year><volume>125</volume><fpage>51</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2015.11.007</pub-id><pub-id pub-id-type="pmid">26611396</pub-id></element-citation></ref><ref id="CR89"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yonesi</surname><given-names>M</given-names></name><name name-style="western"><surname>Kamrani</surname><given-names>A</given-names></name></person-group><article-title>An efficient isolation plan for extraction of the mucilage collected from the seeds within the lallemantia for pharmaceutical purpose</article-title><source>Plant Cell Biotechnol Mol Biol</source><year>2019</year><volume>20</volume><issue>7&#8211;8</issue><fpage>294</fpage><lpage>304</lpage></element-citation></ref><ref id="CR90"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>P</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X-L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X-G</given-names></name><name name-style="western"><surname>Hu</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name><etal/></person-group><article-title>A pneumonia outbreak associated with a new coronavirus of probable bat origin</article-title><source>Nature</source><year>2020</year><volume>579</volume><issue>7798</issue><fpage>270</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2012-7</pub-id><pub-id pub-id-type="pmid">32015507</pub-id><pub-id pub-id-type="pmcid">PMC7095418</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>